<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">78554</article-id><article-id pub-id-type="doi">10.7554/eLife.78554</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title><italic>Schizosaccharomyces pombe</italic> Rtf2 is important for replication fork barrier activity of <italic>RTS1</italic> via splicing of <italic>Rtf1</italic></article-title></title-group><contrib-group><contrib contrib-type="author" id="author-273810"><name><surname>Budden</surname><given-names>Alice M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-308930"><name><surname>Eravci</surname><given-names>Murat</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="pa1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-198624"><name><surname>Watson</surname><given-names>Adam T</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273811"><name><surname>Campillo-Funollet</surname><given-names>Eduard</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa2">‡</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-62587"><name><surname>Oliver</surname><given-names>Antony W</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2912-8273</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-273813"><name><surname>Naiman</surname><given-names>Karel</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3594-1516</contrib-id><email>karel.naiman@inserm.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa3">§</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-136466"><name><surname>Carr</surname><given-names>Antony M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2028-2389</contrib-id><email>A.M.Carr@sussex.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00ayhx656</institution-id><institution>Genome Damage and Stability Centre, University of Sussex</institution></institution-wrap><addr-line><named-content content-type="city">Brighton</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00ayhx656</institution-id><institution>Department of Biochemistry and Biomedicine, University of Sussex</institution></institution-wrap><addr-line><named-content content-type="city">Brighton</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Shinohara</surname><given-names>Akira</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/035t8zc32</institution-id><institution>Osaka University</institution></institution-wrap><country>Japan</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Weigel</surname><given-names>Detlef</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0243gzr89</institution-id><institution>Max Planck Institute for Biology Tübingen</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Medicines and Healthcare Products Regulatory Agency (MHRA), Hertfordshire, United Kingdom</p></fn><fn fn-type="present-address" id="pa2"><label>‡</label><p>Department of Mathematics and Statistics, Lancaster University, Lancaster, United Kingdom</p></fn><fn fn-type="present-address" id="pa3"><label>§</label><p>Cancer Research Center of Marseille (CRCM), INSERM U1068, CNRS, Aix Marseille Université, Institut Paoli-Calmettes, Marseille, France</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>24</day><month>08</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e78554</elocation-id><history><date date-type="received" iso-8601-date="2022-03-11"><day>11</day><month>03</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-08-19"><day>19</day><month>08</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-03-10"><day>10</day><month>03</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.03.10.483798"/></event></pub-history><permissions><copyright-statement>© 2023, Budden et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Budden et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-78554-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-78554-figures-v2.pdf"/><abstract><p>Arrested replication forks, when restarted by homologous recombination, result in error-prone DNA syntheses and non-allelic homologous recombination. Fission yeast <italic>RTS1</italic> is a model fork barrier used to probe mechanisms of recombination-dependent restart. <italic>RTS1</italic> barrier activity is entirely dependent on the DNA binding protein Rtf1 and partially dependent on a second protein, Rtf2. Human RTF2 was recently implicated in fork restart, leading us to examine fission yeast Rtf2’s role in more detail. In agreement with previous studies, we observe reduced barrier activity upon <italic>rtf2</italic> deletion. However, we identified Rtf2 to be physically associated with mRNA processing and splicing factors and <italic>rtf2</italic> deletion to cause increased intron retention. One of the most affected introns resided in the <italic>rtf1</italic> transcript. Using an intronless <italic>rtf1,</italic> we observed no reduction in RFB activity in the absence of Rtf2. Thus, Rtf2 is essential for correct <italic>rtf1</italic> splicing to allow optimal <italic>RTS1</italic> barrier activity.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>replication</kwd><kwd>transcription</kwd><kwd>splicing</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>S. pombe</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>11047/Z/15/Z</award-id><principal-award-recipient><name><surname>Carr</surname><given-names>Antony M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. For the purpose of Open Access, the authors have applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Rtf2 is shown to associate with multiple splicing factors and influence splicing of a subset of introns explaining why previous work erroneously assigned it as a replication restart factor in fission yeast.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The completion of DNA synthesis is crucial for maintaining genome stability and survival but a variety of obstacles to DNA replication have the ability to stall replication forks (<xref ref-type="bibr" rid="bib22">Magdalou et al., 2014</xref>). Stalled forks are usually stabilised by the Intra-S phase checkpoint such that they can ordinarily resume DNA synthesis once the obstacle has been removed or resolved (<xref ref-type="bibr" rid="bib18">Lambert and Carr, 2013</xref>). However, if replication cannot be resumed and/or the replication fork becomes non-functional, this is known as replication fork collapse. In the majority of cases collapsed replication forks are rescued by a convergent fork, allowing the completion of DNA synthesis. Nevertheless, in regions of the genome with a paucity of origins, or when two convergent forks collapse without an intervening origin, collapsed replication forks must be actively restarted in order to complete replication.</p><p>Homologous recombination underpins several mechanisms that have evolved to restart collapsed replication forks. Recombination-dependent replication (RDR) mechanisms include the restart of replication forks following fork reversal plus DNA end processing (<xref ref-type="bibr" rid="bib1">Ait Saada et al., 2018</xref>) and break-induced replication (BIR; <xref ref-type="bibr" rid="bib23">Malkova and Ira, 2013</xref>), where replication is initiated from one end of a DNA double strand break (DSB). Yeast model systems have been instrumental in identifying and characterising RDR mechanisms: BIR has been extensively characterised in <italic>Saccharomyces cerevisiae</italic> and has been shown to occur in G2 phase and to involve initial DSB processing followed by Rad51-dependent strand invasion that results in conservative DNA synthesis via a migrating D-loop. In contrast, DSB-independent RDR (<xref ref-type="bibr" rid="bib25">Mizuno et al., 2009</xref>) has been characterised mainly in <italic>Schizosaccharomyces pombe</italic> and has been shown to involve fork reversal, processing of the resulting DNA double strand end and Rad51-dependent strand invasion that results in semi-conservative replication (<xref ref-type="bibr" rid="bib37">Teixeira-Silva et al., 2017</xref>; <xref ref-type="bibr" rid="bib24">Miyabe et al., 2015</xref>).</p><p>A key tool used in <italic>S. pombe</italic> to investigate the mechanisms involved in replication fork arrest, collapse and restart is a site-specific replication fork barrier (RFB) that was initially identified close to the mating type locus (<xref ref-type="bibr" rid="bib9">Dalgaard and Klar, 2000</xref>). This RFB, known as <italic>RTS1</italic> (Replication Termination Sequence 1), acts to ensure that replication across the mating type locus is unidirectional. It achieves this by acting as a polar barrier – i.e. it only arrests replication forks travelling from a single ‘restrictive’ direction (<xref ref-type="bibr" rid="bib10">Dalgaard and Klar, 2001</xref>). Forks travelling in the opposite ‘permissive’ direction are unaffected by the barrier. The <italic>RTS1</italic> barrier was first defined as an 859 bp <italic>Eco</italic>RI fragment that was further refined into two regions, A and B, by deletion analysis. Region B contains four repeat sequences that bind to a Myb-domain protein, known as Rtf1 (Replication Termination Factor 1). Fork arrest at <italic>RTS1</italic> is entirely dependent on Rft1 binding (<xref ref-type="bibr" rid="bib12">Eydmann et al., 2008</xref>) and, in the absence of Rtf1, replication of the <italic>RTS1</italic> sequence is entirely normal. In contrast, region A is defined as being required for enhancing barrier activity. Loss of region A has been reported to reduce barrier activity by approximately three quarters and this function was described as being dependent on a second protein, Rtf2 (<xref ref-type="bibr" rid="bib7">Codlin and Dalgaard, 2003</xref>).</p><p>Interestingly, while Rtf1 appears to be <italic>S. pombe</italic> specific and is not evolutionarily conserved beyond the Myb-like DNA binding domain (<xref ref-type="bibr" rid="bib12">Eydmann et al., 2008</xref>), Rtf2 is conserved in many eukaryotes including humans (<xref ref-type="bibr" rid="bib7">Codlin and Dalgaard, 2003</xref>). Rtf2 belongs to a family of proteins that are characterised by a C2HC2 Ring Finger motif predicted to fold up into a RING-finger structure with the ability to bind one Zn<sup>2+</sup> ion (<xref ref-type="bibr" rid="bib13">Inagawa et al., 2009</xref>) and is likely to mediate protein-protein interactions. Studies in human cells have shown that <italic>Hs</italic>RTF2 acts to reduce the levels of replication fork restart and thus its removal from arrested replication forks via proteasomal shuttle proteins (DDI1 and DDI2) is important to allow replication fork restart to occur (<xref ref-type="bibr" rid="bib17">Kottemann et al., 2018</xref>). Additionally, the nuclear receptor interacting protein 3 (NIRP3) has been shown to upregulate DDI1 and increase polyubiquitylation of <italic>Hs</italic>RTF2, promoting <italic>Hs</italic>RTF2 removal and replication fork restart upon replication stress (<xref ref-type="bibr" rid="bib36">Suo et al., 2020</xref>). Within disease models, <italic>Hs</italic>RTF2 has also been identified as a causal factor for Alzheimer’s Disease, although the exact mechanism remains unclear (<xref ref-type="bibr" rid="bib29">Ou et al., 2021</xref>; <xref ref-type="bibr" rid="bib42">Wingo et al., 2021</xref>). To further elucidate the conserved function of Rtf2 at stalled replication forks, we investigated this protein further using a previously described <italic>RTS1</italic>-RFB system in <italic>S. pombe</italic> (<xref ref-type="bibr" rid="bib28">Naiman et al., 2021</xref>).</p><p>In agreement with previous studies on Rtf2 at the <italic>RTS1</italic> RFB<italic>,</italic> we observe reduced barrier activity upon <italic>rtf2</italic> deletion as assayed both by polymerase-usage sequencing (Pu-seq) and a replication slippage assay. However, in our system, the mechanism of action of Rtf2 at <italic>RTS1</italic> does not occur via region A of <italic>RTS1,</italic> as had been previously reported. Using a proximity-based mass spectrometry method, we identified Rtf2 to be physically associated with mRNA processing and splicing factors. cDNA-Seq of mature polyA-mRNA revealed a modest global increase in the levels of intron retention in <italic>rtf2</italic>Δ cells. Intron retention was not uniform and specifically affected a subset of introns, with one of the most affected introns residing within the <italic>rtf1</italic> transcript. Using an intronless <italic>rtf1</italic> (<italic>rtf1</italic>Δ<italic>int</italic>), that does not require splicing to encode a functional Rtf1 protein, we find that, in the absence of Rtf2, there was no reduction in RFB activity in comparison to when Rtf2 is present. These data demonstrate that the presence of Rtf2 is essential for the correct splicing of the <italic>rtf1</italic> transcript in order to allow optimal barrier activity at <italic>RTS1</italic>.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Rtf2 is important for efficient barrier activity at RTS1</title><p>We have previously shown that RDR initiated at <italic>RTS1</italic> results in the formation of a non-canonical replication fork where DNA is semi-conservatively replicated with polymerase delta synthesising both the leading and the lagging strands (<xref ref-type="bibr" rid="bib24">Miyabe et al., 2015</xref>). Interestingly, the resulting replication is error prone (<xref ref-type="bibr" rid="bib26">Mizuno et al., 2013</xref>), showing elevated replication slippage events (<xref ref-type="bibr" rid="bib14">Iraqui et al., 2012</xref>). The non-canonical nature of the RDR fork provides us with two tools to follow replication restart: first, we can estimate the percentage usage of non-canonical replication from the levels of replication slippage measured using a genetic reporter that reconstitutes uracil prototrophy (<xref ref-type="bibr" rid="bib14">Iraqui et al., 2012</xref>). Second, we can track DNA polymerase movement, and thus non-canonical RDR forks, using a recently developed Polymerase-usage sequencing (Pu-seq) method (<xref ref-type="bibr" rid="bib28">Naiman et al., 2021</xref>). In brief, Pu-seq utilises pairs of mutant <italic>S. pombe</italic> strains, each harbouring an rNTP permissive mutation in the catalytic subunit of either of the main replicative polymerases (Polε or Polδ; <xref ref-type="bibr" rid="bib16">Keszthelyi et al., 2015</xref>). In a ribonucleotide excision repair deficient background this allows rNMPs to persist in the DNA strand that is replicated by the mutant polymerase and enables subsequent strand-specific mapping of replication by each of the main replicative DNA polymerases (<xref ref-type="bibr" rid="bib8">Daigaku et al., 2015</xref>).</p><p>In order to use Pu-seq to study the HR-restarted replication fork with minimal interference from converging canonical replication forks, the <italic>RTS1</italic> barrier sequence has been placed in a region of the genome next to an early firing origin with a distant late firing origin downstream (<xref ref-type="bibr" rid="bib28">Naiman et al., 2021</xref>; <xref ref-type="fig" rid="fig1">Figure 1A</xref>). Thus, the predominant orientation of canonical replication across this region is in a rightward direction. The <italic>RTS1</italic> sequence has been inserted in the orientation that arrests replication forks originating from the early firing origin, but which is permissive to those originating from the late firing origin. In addition, to delay any replication forks initiating downstream of <italic>RTS1</italic> and thus increase the time available for replication forks blocked at <italic>RTS1</italic> to restart and replicate the downstream region, we inserted, 10 x ribosomal DNA RFB (rRFB) sequences (<italic>Ter2-Ter3</italic>) ~10 Kb downstream of <italic>RTS1</italic>. The rRFB is also polar and we have inserted the 10 x array in the orientation that will pause RFs originating from the late firing origin. The rRFBs do not collapse replications forks (<xref ref-type="bibr" rid="bib26">Mizuno et al., 2013</xref>), do not utilise homologous recombination (HR) for restart (<xref ref-type="bibr" rid="bib4">Calzada et al., 2005</xref>) and do not result in non-canonical replication forks that synthesise both strands with Polδ (<xref ref-type="bibr" rid="bib28">Naiman et al., 2021</xref>). To allow comparison of HR-restarted replication forks to unhindered canonical replication forks, the <italic>RTS1</italic> RFB activity is controlled by the presence/absence of Rtf1 (<italic>rtf1<sup>+</sup></italic>+ON, <italic>rtf1Δ</italic>=OFF).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Rtf2 deletion reduces replication fork restart at <italic>RTS1</italic>.</title><p>(<bold>A</bold>) The <italic>RTS1</italic> sequence (grey box) is inserted between an early and a late firing replication origin and 10 ribosomal replication fork barriers (10 x rRFB, orange box) are inserted ~10 Kb downstream of <italic>RTS1</italic>. The predominant direction of replication is shown with canonical (black) and restarted replication forks (red) indicated. (<bold>B</bold>) Polymerase usage around the <italic>RTS1</italic> RFB locus in <italic>rtf2</italic><sup>+</sup> cells. <italic>RTS1</italic> OFF (left panel) and ON (right panel). The ratio of Polymerase ε (red) and Polymerase ẟ (blue) for both the top and bottom strand is shown. (<bold>C</bold>) Polymerase usage around the <italic>RTS1</italic> RFB locus in <italic>rtf2</italic>Δ cells. <italic>RTS1</italic> OFF: rtf1Δ rtf2Δ. <italic>RTS1</italic> ON: <italic>rtf1</italic><sup>+</sup> <italic>rtf2</italic>Δ. Panel details as in B. (<bold>D</bold>) Polymerase bias graph calculated using the ratio of polymerase usage across both strands around the <italic>RTS1</italic> RFB locus. (<bold>E</bold>) Schematic of the <italic>RTS1</italic>-RFB replication slippage assay. A <italic>ura4</italic> allele containing a 20 bp tandem repeat (<italic>ura4-sd20</italic>) is inserted immediately downstream of the <italic>RTS1</italic> sequence. Replication slippage can result in loss of one repeat, which manifests as ura<sup>+</sup>. (<bold>F</bold>) Replication fork slippage events scored as the frequency of <italic>ura4</italic><sup>+</sup> reversions over 2 cell cycles using the <italic>RTS1-ura4-sd20</italic> replication fork slippage assay. Data from three independent experiments ± SD. Statistical analysis by two-tailed Students T-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78554-fig1-v2.tif"/></fig><p>Polymerase-usage Sequencing (Pu-seq) was first performed on strains containing the <italic>RTS1</italic> construct with either the barrier activity OFF (<italic>rtf1Δ</italic>) and barrier activity ON (<italic>rtf1</italic><sup>+</sup>) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). When <italic>RTS1</italic> is OFF (<italic>rtf1Δ</italic>) the <italic>RTS1</italic> sequence and the ~10 kb to the right is replicated by Polε on the top strand and by Polẟ on the bottom strand. This is consistent with predominant replication by rightward moving canonical forks. When the <italic>RTS1</italic> barrier is ON (<italic>rtf1</italic><sup>+</sup>), there is an abrupt switch to Polẟ usage on the top strand at the point at which <italic>RTS1</italic> has been inserted and the downstream region is replicated with both strands being synthesised by Polẟ. This confirms that RDR is initiated at <italic>RTS1</italic> in most cells in the population, with both strands largely being replicated by a non-canonical fork across a region of ~10 kb.</p><p>As discussed above, Rtf2 has been reported to enhance the fork arrest at active <italic>RTS1</italic> when replication structures are visualised by 2D gels (<xref ref-type="bibr" rid="bib7">Codlin and Dalgaard, 2003</xref>). To investigate how Rtf2 affects the dynamics of polymerase usage downstream of the <italic>RTS1</italic> RFB, Pu-seq was next conducted in <italic>rtf2</italic>Δ cells. As expected, canonical replication is evident across <italic>RTS1</italic> and the downstream region when the barrier is OFF (<italic>rtf1</italic>Δ, <italic>rtf2</italic>Δ) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). When <italic>RTS1</italic> is ON (<italic>rtf1</italic><sup>+</sup> <italic>rtf2</italic>Δ), the switch from Polε usage to Polẟ usage on the top is reduced at the site of <italic>RTS1</italic> when compared to <italic>rtf2</italic><sup>+</sup> cells and Polẟ usage on the top (leading) strand across the ~10 kb downstream region is also reduced. This indicates that, when compared to <italic>rtf2</italic><sup>+</sup>, a significantly reduced proportion of cells in the <italic>rtf2</italic>Δ population arrest the replication fork and switch to RDR to replicate the region downstream of the barrier (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). This is particularly evident when the ratio of polymerase usage across both strands is calculated (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). For canonical replication this is calculated to be Polẟ:Polε=50:50, whereas with increasing levels of RDR in the population the same calculations are expected to generate a bias towards Polẟ:Polε=100:0. In <italic>rtf2</italic><sup>+</sup> cells, there is a clear Polymerase ẟ bias at and downstream of active <italic>RTS1</italic> (ON: <italic>rtf2</italic><sup>+</sup>; <xref ref-type="fig" rid="fig1">Figure 1D</xref>). However, when <italic>rtf2</italic> is deleted the level of Polẟ bias produced at and downstream of the <italic>RTS1</italic> barrier sequence is reduced. As expected, in the absence of <italic>rtf1</italic> (OFF: <italic>rtf1</italic>Δ) the ratio of Polẟ:Polε=approximately 50:50, irrespective of the presence or absence of <italic>rtf2</italic>.</p><p>We further confirmed these findings by measuring the level of mutagenesis at a region potentially replicated by the restarted replication fork. To assay mutagenesis the <italic>ura4-sd20</italic> allele<italic>,</italic> which contains a 20 bp tandem repeat and renders cells uracil dependent (<xref ref-type="bibr" rid="bib14">Iraqui et al., 2012</xref>), was integrated immediately downstream of the <italic>RTS1</italic> barrier (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Deletion of one tandem repeat by replication slippage will revert the allele to <italic>ura4</italic><sup>+</sup>, resulting in uracil prototrophic cells. These events can subsequently be selected for, and quantified, as a readout for replication fork slippage events. In <italic>rtf2</italic><sup>+</sup> cells, the activation of <italic>RTS1</italic> results in a large increase in replication fork slippage events in the downstream region when compared to cells where <italic>RTS1</italic> is OFF (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). For <italic>rtf2</italic>Δ cells, there is a reduction in replication fork slippage events downstream of an active <italic>RTS1</italic> in comparison to <italic>rtf2</italic><sup>+</sup> cells, but this was not reduced to the low levels seen when <italic>RTS1</italic> was OFF. This reduction in replication fork slippage when <italic>rtf2</italic> is deleted is fully consistent with, and likely reflects, the reduced levels of restarted replication forks evident in the Pu-seq traces.</p><p>Taken together, these results suggest that an increased proportion of replication forks remain canonical (ε/ẟ) after encountering the <italic>RTS1</italic> RFB in the absence of Rtf2, with only around a third of replication forks (based on the proportion of polymerase bias of <italic>rtf2</italic>Δ compared to <italic>rtf2</italic><sup>+</sup>) arresting and restarting using non-canonical (ẟ/ẟ) replication. Therefore, in <italic>rtf2</italic>Δ cells, only a subset of replication forks block at <italic>RTS1</italic> and restart via RDR when compared to the <italic>rft1</italic><sup>+</sup>. The other replication forks either arrest briefly at <italic>RTS1</italic> and resume as a canonical replication fork, or they do not get blocked at <italic>RTS1</italic> and instead continue replication across the region as in an <italic>RTS1</italic> OFF situation.</p></sec><sec id="s2-2"><title>Rtf2 does not increase RTS1 barrier activity via interactions with enhancer region A</title><p><italic>RTS1</italic> is annotated as being composed of two main regions, A and B (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Region B contains four repetitive sequence motifs and is proposed to bind Rtf1 (<xref ref-type="bibr" rid="bib7">Codlin and Dalgaard, 2003</xref>). It has previously been reported that Rtf2 enhances <italic>RTS1</italic> barrier activity by either direct or indirect association with region A. This was because a similar and non-additive reduction in the blocking signal (monitored by 2D gel electrophoresis) was observed for a plasmid-borne <italic>RTS1</italic> construct lacking region A as was evident in <italic>rtf2</italic>Δ cells (<xref ref-type="bibr" rid="bib7">Codlin and Dalgaard, 2003</xref>). To confirm this observation in our <italic>RTS1</italic> system and characterise any impact of region A on polymerase usage downstream of an active (<italic>rtf1</italic><sup>+</sup>) <italic>RTS1</italic>, region A was deleted from the <italic>RTS1</italic> sequence and the modified <italic>RTS1_A</italic>Δ construct inserted to replace <italic>RTS1</italic>. The modified locus still contains the downstream 10xrRFBs. The truncated <italic>RTS1_A</italic>Δ sequence was also incorporated into the replication fork slippage construct, to produce <italic>RTS1_A</italic>Δ:<italic>ura4-sd20</italic>. If Rtf2 is performing an enhancing function for arrest at <italic>RTS1</italic> via region A, the same profiles of mutagenesis and polymerase usage would be expected for <italic>rtf2</italic>Δ and <italic>RTS1_A</italic>Δ.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>RTS1</italic> region A is dispensable for efficient replication fork restart.</title><p>(<bold>A</bold>) Schematic of the <italic>RTS1</italic> RFB. Region A is a~60 bp purine rich region and Region B is ~450 bp containing the four repeated sequence motifs essential for <italic>RTS1</italic> activity. (<bold>B</bold>) Replication fork slippage events scored as the frequency of <italic>ura4</italic><sup>+</sup> reversions over two cell cycles. Data from three independent experiments ± SD. Statistical analysis by two-tailed Students T-test, p<italic>&gt;0.05</italic> = not significant (<italic>ns</italic>). (<bold>C</bold>) Polymerase usage around the <italic>RTS1_A</italic>Δ RFB locus for RFB OFF (Top panel) and ON (bottom left panel) for <italic>rtf2</italic><sup>+</sup> and polymerase usage around the <italic>RTS1_A</italic>Δ RFB locus in <italic>rtf2</italic>Δ cells with the barrier ON (bottom right panel). For each panel the ratio of Polymerase ε (red) and Polymerase ẟ (blue) for both the top and bottom strand is shown along with a polymerase bias graph calculated using the ratio of polymerase usage across both strands and comparing <italic>RTS1_A</italic>Δ (orange) with the <italic>RTS1</italic> locus (black).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78554-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Mud1 does not impact the turnover of Rtf2 or cell sensitivity to HU/MMS<italic>.</italic></title><p><italic>(</italic><bold>A</bold>) The absence of Mud1 does not reduce cell viability in the presence of HU/MMS. Cells were spotted onto plates in 10 x serial dilutions and incubated at 30 °C for 4 days. (<bold>B</bold>) Cycloheximide treatment of cells containing Rtf2-3HA with (<italic>mud1<sup>+</sup></italic>) and without (<italic>mud1</italic>Δ) Mud1 over the course of 10 min post-treatment. Presence of Rtf2 probed with anti-HA, and tubulin probed for with anti-tubulin as a loading control.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78554-fig2-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78554-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Uncropped blots for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78554-fig2-figsupp2-v2.tif"/></fig></fig-group><p>We first monitored the levels of mutagenesis downstream of <italic>RTS1</italic> using <italic>RTS1:ura4-sd20</italic> and <italic>RTS1_A</italic>Δ:<italic>ura4-sd20</italic> (<xref ref-type="fig" rid="fig2">Figure 2B</xref>) loci. Similar basal levels of replication fork slippage were seen in both systems when <italic>RTS1</italic> was OFF (<italic>rtf1</italic>Δ). As expected, replication fork slippage rates were also similar when <italic>rtf2</italic> is deleted in both systems when the barrier is ON (<italic>rtf1</italic><sup>+</sup><italic>rtf2</italic>Δ). If region A is required for the enhancing effect on fork arrest at <italic>RTS1</italic> by Rtf2, the levels of replication fork slippage when the barrier is ON would be expected to be reduced in <italic>RTS1_A</italic>Δ <italic>rtf2</italic><sup>+</sup> cells to the same level as seen in <italic>RTS1 rtf2</italic>Δ. However, this was not the case and equivalent levels of replication fork slippage are observed for both <italic>RTS1</italic> and <italic>RTS1_A</italic>Δ constructs in the ON (<italic>rtf1</italic><sup>+</sup> <italic>rtf2</italic><sup>+</sup>) state. This suggests that region A is dispensable for <italic>RTS1</italic> arrest and RDR restart efficiency in our system and is not likely to be a site of Rtf2 function.</p><p>To establish the extent of RDR occurring in the absence of region A, Pu-seq was performed on strains containing the <italic>RTS1_A</italic>Δ system. As expected, when barrier activity was OFF (<italic>rtf1</italic>Δ) replication was canonical across the region, as has previously been seen for <italic>RTS1</italic> (<xref ref-type="fig" rid="fig2">Figure 2C</xref>; top). When the barrier was ON (<italic>rtf1</italic><sup>+</sup>), the same levels of Polẟ bias (representing non-canonical RDR) was observed for <italic>RTS1_A</italic>Δ as was seen for <italic>RTS1</italic> (<xref ref-type="fig" rid="fig2">Figure 2C</xref>; bottom left). Similarly, when the barrier activity was ON and Rtf2 function was absent (<italic>rtf1</italic><sup>+</sup>, <italic>rtf2</italic>Δ) the same reduced level of Polẟ bias was observed for both <italic>RTS1_A</italic>Δ and <italic>RTS1</italic> (<xref ref-type="fig" rid="fig2">Figure 2C</xref>; bottom right). Taken together, these results indicate that Rtf2 does not specifically interact with, or function through, region A and that region A is dispensable for normal levels of fork arrest and restart by RDR at this locus.</p></sec><sec id="s2-3"><title>DDI1 homolog in <italic>S. pombe</italic> (Mud1) is not responsible for the degradation Of Rtf2</title><p>Having shown that Rtf2 is not interacting with <italic>RTS1</italic>, we aimed to determine if Rtf2 was playing a similar role through <italic>RTS1</italic> as had been suggested for its role at stalled replication forks in human cells (<xref ref-type="bibr" rid="bib17">Kottemann et al., 2018</xref>; <xref ref-type="bibr" rid="bib36">Suo et al., 2020</xref>). Human RTF2 is removed from stalled replication forks and targeted to the proteasome via proteasomal shuttle proteins DDI1/2. To establish if <italic>S. pombe</italic> Rft2 is a client protein for the equivalent proteasomal shuttle, we deleted the <italic>S. pombe</italic> gene encoding the DDI1/2 homolog, <italic>mud1</italic> (<xref ref-type="bibr" rid="bib38">Trempe et al., 2005</xref>), and determined cell sensitivity to agents capable of stalling replication forks (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). DDI1/2 knockdown in human cells sensitises to HU treatment, and <italic>S. pombe rtf2</italic>Δ cells are sensitive to high levels of MMS. Deletion of <italic>mud1</italic> did not result in sensitivity to MMS (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>) and a double deletion mutant, <italic>mud1</italic>Δ <italic>rtf2</italic>Δ<italic>,</italic> displayed no increase in MMS sensitivity in comparison to <italic>rtf2</italic>Δ alone. Similarly, no sensitivity to HU was observed for <italic>mud1</italic>Δ, <italic>rtf2</italic>Δ or the double <italic>mud1</italic>Δ <italic>rtf2</italic>Δ. These results suggest that Mud1 does not play the same role as has been observed for human DDI1/2 proteins.</p><p>To further investigate the equivalence between Mud1 and human DDI1/2, we monitored the turnover of Rtf2 in the presence and absence of Mud1. Upon treatment with cycloheximide, a translation inhibitor, the levels of Rtf2 are rapidly decreased (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). In a <italic>mud1</italic>Δ background, the rate of Rtf2 degradation was equivalent to <italic>mud1<sup>+</sup></italic> +. This further suggests that Mud1 is not playing the same role in regulating Rtf2 in <italic>S. pombe</italic> as has been observed for DDI1/2 in human cells.</p></sec><sec id="s2-4"><title>Rtf2 is associated with mRNA processing and splicing factors</title><p>Having established that Rtf2 is not enacting its role on the levels of replication fork restart at <italic>RTS1</italic> via interaction with region A, we sought to investigate if it is instead travelling with the replication fork, as has been suggested for human RTF2 (<xref ref-type="bibr" rid="bib17">Kottemann et al., 2018</xref>). A proximity biotin labelling-based mass spectrometry method, TurboID (<xref ref-type="bibr" rid="bib3">Branon et al., 2018</xref>), was used to identify associated proteins. TurboID utilises a mutant version of the <italic>E. coli</italic> BirA biotin ligase (TbID) that catalyses biotin into biotinoyl-5’-AMP, which subsequently covalently attaches to proteins within close proximity (<xref ref-type="bibr" rid="bib6">Choi-Rhee et al., 2004</xref>). Rtf2 was C-terminally tagged with BirA<sup>TbID</sup> and an internal 3 HA tag. To establish if the tag negated Rtf2 function, a spot test was conducted to monitor sensitivity to high levels of MMS (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). There was no evident sensitivity of <italic>rtf2-3HA-TurboID</italic> cells, indicating the tag did not negate Rtf2 function.</p><p><italic>rtf2-3HA-TurboID</italic> and control <italic>rtf2</italic><sup>+</sup> cells were synchronised in S phase to enrich for replication (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>) structures or treated with MMS to enrich for stalled/collapsed replication forks. Following biotin addition, purification of biotin tagged proteins by streptavidin affinity and mass spectrometry, proteins that were enriched with statistical significance in comparison to no TurboID tag were identified for both conditions (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). As expected, Rtf2 was identified as a hit with a large increase in abundance. A number of additional proteins were also identified as being significantly enriched in the <italic>rtf2-3HA-TurboID</italic> cells, and thus predicted to be in close proximity to the Rtf2<sup>TbID</sup> (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). To determine which processes Rtf2 may be involved in, GO Term analysis was conducted on all significant hits for each condition (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref> and <xref ref-type="supplementary-material" rid="supp2 supp3">Supplementary files 2 and 3</xref>). Based on the identification of human RTF2 as a replication factor, GO Terms associated with replication and associated processes were expected to be identified. Surprisingly, no such GO Terms were associated with the proteins identified as being in close proximity to Rtf2. Instead, the top GO Terms that arise are those to do with mRNA processing and splicing. This supports previous mass spectrometry results for <italic>Arabadopsis Thaliana</italic> Rtf2 (<italic>At</italic>Rtf2), which similarly identified splicing factors as Rtf2 interactors (<xref ref-type="bibr" rid="bib34">Sasaki et al., 2015</xref>). Additionally, this is in concordance with a genome wide screen in <italic>S. pombe</italic> that identified Rtf2 as affecting splicing of two reporter introns (<xref ref-type="bibr" rid="bib20">Larson et al., 2016</xref>).</p></sec><sec id="s2-5"><title>Rtf2 deletion results in increased intron retention</title><p>To test if Rtf2 has an effect on splicing patterns, long-read direct cDNA-sequencing was conducted using an Oxford Nanopore MinION sequencer (<xref ref-type="bibr" rid="bib15">Jain et al., 2015</xref>). Differential splicing can be efficiently identified by sequencing full length cDNA created from polyA-mRNA transcripts (<xref ref-type="bibr" rid="bib2">Bolisetty et al., 2015</xref>). The polyA tail is only added to mature mRNA allowing the polyA tail to be used for purification of only those transcripts that have completed splicing. Sequencing was carried out on cDNA derived from polyA-mRNA samples from <italic>rtf2</italic><sup>+</sup> and <italic>rtf2</italic>Δ cells to get an overview of alterations to splicing patterns across entire transcripts. Sequencing reads were mapped to the genome using minimap2 (<xref ref-type="bibr" rid="bib21">Li, 2018</xref>) and mapped transcripts were compared to the annotated transcripts using GffCompare (<xref ref-type="bibr" rid="bib30">Pertea and Pertea, 2020</xref>), which reports statistics (see <xref ref-type="fig" rid="fig3">Figure 3A</xref> right and <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>) relating to the measure of agreement of the input transcripts when compared to reference annotation.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title><italic>rtf2</italic>Δ results in increased retention of a subset of introns including within the <italic>rtf1</italic> transcript<italic>.</italic></title><p><italic>(</italic><bold>A</bold>) GffCompare classification analysis of transcripts from WT (grey) and <italic>rtf2</italic>Δ (yellow) samples. Graph shows the mean of three biological repeats with error bars representing SD. The table (right) describes each classification. (<bold>B</bold>) Graph showing the difference in intron retention for each individual intron with a normal distribution curve fitted. Introns that show no difference between WT and <italic>rtf2</italic>Δ are not included on the graph. (<bold>C</bold>) Depth of reads mapped across the <italic>rtf1</italic> transcript for WT (grey) and <italic>rtf2</italic>Δ (yellow) samples. Corresponding transcripts as calculated by GffCompare are shown above. (<bold>D</bold>) Two repeats of PCR amplification of intron 2 and intron 6 from cDNA derived from polyA-mRNA. Schematic shows the principle behind the shift in size from a smaller band, representing correctly spliced, to a larger band, representing a retained intron. (<bold>E</bold>) Whole cell extract of <italic>V5-rtf1</italic> containing cells in WT and <italic>rtf2</italic>Δ background probed with indicated antibody. Cdc2 is shown as a loading control.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78554-fig3-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78554-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Proximal Proteins of Rtf2 identified via TurboID Proximity Based Labelling Mass Spectrometry<italic>.</italic></title><p><italic>(</italic><bold>A</bold>) The presence of Rtf2-3HA-BirA<sup>TbID</sup> does not reduce cell viability in the presence of MMS to that of <italic>rtf2</italic>Δ. Cells were spotted onto plates in 10 x serial dilutions and incubated at 30 °C for 4 days. (<bold>B</bold>) FACS analysis of cells synchronised in G2 and S phase using the <italic>cdc2asM17</italic> ATP-sensitive allele. (<bold>C</bold>) Volcano plot of mass spectrometry protein hits. Proteins are plotted as p value against fold change calculated using Welch’s T-test. Identified splicing factors are indicated. (<bold>D</bold>) GO Term analysis of significant protein hits (p&lt;0.01) with a fold change of &gt;2.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78554-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>cDNA-Seq analysis of retained introns<italic>.</italic></title><p><italic>(</italic><bold>A</bold>) Gene expression analysis between <italic>rtf2</italic><sup>+</sup> and <italic>rtf2</italic>Δ samples using TPM (Transcripts Per Million) as calculated by GffCompare. Spearmans Rank correlation coefficient and associated p value are shown. <italic>Left graph</italic>: Total transcripts; <italic>Middle graph</italic>: Transcripts classified as Type ‘m’ by GffCompare; <italic>Right graph</italic>: Intron containing transcripts (<italic>rtf2Δ</italic>&gt;20% retention = yellow, WT &gt;20% retention = red, no retention = grey). (<bold>B</bold>) Histogram of intron length for introns retained (IR) at the indicated percentage for <italic>rtf2</italic>Δ samples. (<bold>C</bold>) Rolling average of GC richness (rolling window of 40 bp) for introns and the following exon aligned around the centre of the branch point (BP) motif. <italic>Top graph</italic>: different subsets of intron:exon sequences based on difference in intron retention (IR; <italic>rtf2</italic>Δ – WT); <italic>Middle graph</italic>: Random represents GC richness of 100 random intron:exon sequences with error bars representing the 95% confidence intervals. <italic>Bottom graph</italic>: Middle graph with added actual G/C content from intron 2 and intron 6 of <italic>rtf1</italic>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78554-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Uncropped blots for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78554-fig3-figsupp3-v2.tif"/></fig></fig-group><p>The proportion of reads for each type of mapped transcript did not vary significantly between <italic>rtf1</italic><sup>+</sup> and <italic>rtf2</italic>Δ, except for those indicating an intron retention event (type ‘m’) (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Having observed an increase in intron retention at the transcript level, we sought to confirm this via quantification of retention for each individual intron. Quantifying the fraction of mapped reads that span each intron vs. those that lack the intron and only map to the two flanking exons confirmed a shift toward increased intron retention in <italic>rtf2</italic>Δ cells (<xref ref-type="fig" rid="fig3">Figure 3B</xref> and <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). Deletion of <italic>rtf2</italic> increases intron retention in only a subset of total introns, with 43 genes consistently resulting in transcripts with an intron retention event occurring 20% more often in at least 2 of three repeats in comparison to <italic>rtf2</italic><sup>+</sup> (<xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). However, this number is likely an underestimate due to reduced read depth of low expression genes as well as degradation to the 5’ end of some transcripts.</p><p>Of the increased intron retention transcripts, the <italic>RTS1</italic> DNA binding factor <italic>rtf1</italic> was identified, whose activity is crucial for the barrier activity (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Visual inspection of the transcript map produced from GffCompare clearly shows intron 2, which is usually an efficiently spliced intron, persists in essentially all the transcripts sequenced (type: ‘m’). A second <italic>rtf1</italic> intron, intron 6, is also affected, showing retention in a proportion of the transcripts. The GffCompare transcript map shows that <italic>rtf1</italic> transcripts from <italic>rtf2</italic><sup>+</sup> cells splice all introns effectively: i.e., are classed as equivalent to the reference genome (type: ‘=’) and a single predominant transcript is predicted. However, two predominant <italic>rtf1</italic> transcripts were predicted by GffCompare for <italic>rtf2</italic>Δ cells, both of which retain intron 2 and one of which also retained intron 6 (type: ‘m’). To confirm these results, PCR amplification of each of these introns from cDNA derived from mature polyA-mRNA was performed (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Upper bands indicate the intron-retained isoform, while the lower bands indicate the correctly spliced isoform. For intron 2, the spliced isoform is undetectable, consistent with the read coverage from the cDNA-Seq data. There is a modest increase in the retained isoform for intron 6 in <italic>rtf2</italic>Δ in comparison to <italic>rtf1</italic><sup>+</sup>. These data are fully consistent with the role of Rtf2 at <italic>RTS1</italic> being indirect, having its effect via ensuring the correct splicing of <italic>rtf1</italic>.</p><p>The subset of genes identified as having introns retained in <italic>rtf2</italic>Δ cells were analysed further. There were no obvious changes to overall gene expression or expression of ‘intron-retained’ (GffCompare group ‘m’) genes when analysing the abundance of transcripts between <italic>rtf2</italic>Δ and <italic>rtf1</italic><sup>+</sup> (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>). The length of intron did not correlate with changes to intron retention (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B</xref>). The only correlation identified was a decrease in GC richness across the branch point (BP), 3’ splice site (3’SS) and the first ~100 bp of the downstream exon in those introns with the highest rates of intron retention (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2C</xref>). This reduction in GC richness fell outside of the 95% confidence interval calculated for a sample of 100 intron:exon sequences indicating this decreased GC content as a significant pre-requisite for the increased intron retention in <italic>rtf2</italic>Δ cells.</p></sec><sec id="s2-6"><title>Intronless rtf1 rescues the rtf2Δ phenotype restoring full RTS1 RFB activity</title><p>Intron 2 of the <italic>rtf1</italic> gene is 45 bp and, if not spliced, the adjacent exons remain in frame and a 15 amino acid insertion is predicted to occur between amino acids 202–203. To establish how the intron retention of <italic>rtf1</italic> in <italic>rtf2</italic>Δ cells effects the final protein product, we N-terminally tagged <italic>rtf1</italic> with a V5 tag and performed a western blot on a whole cell extract (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). The protein levels of Rtf1 do not vary between <italic>rtf2</italic><sup>+</sup> and <italic>rtf2</italic>Δ cells. However, there is a small upward shift in the migration of the protein in <italic>rtf2</italic>Δ cells, which likely corresponds to the small increase in protein size expected from intron 2 retention.</p><p>Rtf2 clearly plays an important role in the correct splicing of <italic>rtf1</italic> mRNA. Incorrect splicing of the <italic>rtf1</italic> transcript could reduce the functionality of the protein and result in reduced binding to <italic>RTS1</italic> or the inefficient blocking of replication forks at this sequence. To test if the increased intron retention in <italic>rtf1</italic> mRNA is indeed responsible for reduced <italic>RTS1</italic> activity in <italic>rtf2</italic>Δ cells, we replaced the wildtype <italic>rtf1</italic> gene with an intronless <italic>rtf1</italic> gene (<italic>rtf1</italic>Δ<italic>int</italic>) at its native locus (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). When transcribed, <italic>rtf1</italic>Δ<italic>int</italic> can no longer retain an intron and thus will mimic the largely efficient splicing that occurs in a <italic>rtf2</italic><sup>+</sup> background (c.f. <xref ref-type="fig" rid="fig3">Figure 3C</xref>). To establish if <italic>rtf1</italic>Δ<italic>int</italic> rescues the defect at <italic>RTS1</italic> RFB in <italic>rtf2</italic>Δ cells we first tested this allele in the replication fork slippage assay (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). When <italic>RTS1</italic> is ON, both <italic>rtf1<sup>+</sup></italic> and intronless <italic>rtf1</italic>Δ<italic>int</italic> exhibit the same levels of replication fork slippage downstream of <italic>RTS1,</italic> indicating similar barrier functionality. However, when <italic>rtf2</italic> is deleted in the presence of <italic>rtf1</italic>Δ<italic>int</italic>, fork slippage levels do not drop to the level seen in <italic>rtf2</italic>Δ <italic>rtf1</italic><sup>+</sup> cells, and instead remains at the higher frequency seen for <italic>rtf2</italic><sup>+</sup> <italic>RTS1</italic> ON. This increase in mutagenicity downstream of <italic>RTS1</italic> for <italic>rtf1</italic>Δ<italic>int</italic> in <italic>rtf2</italic>Δ cells indicates the <italic>RTS1</italic> RFB activity is restored to <italic>rtf2</italic><sup>+</sup> levels in the absence of Rtf2.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Intronless <italic>rtf1</italic> rescues the <italic>rtf2</italic>Δ phenotype restoring full <italic>RTS1</italic> RFB activity<italic>.</italic></title><p><italic>(</italic><bold>A</bold>) Representative schematic of the <italic>rtf1</italic><sup>+</sup> gene containing both exons and introns, and the intronless version, <italic>rtf1</italic>Δ<italic>int</italic> that contains only exons. <italic>rtf1</italic>Δ<italic>int</italic> was inserted at the native locus and is under the control of the native promoter. (<bold>B</bold>) Replication fork slippage events scored as the frequency of <italic>ura4</italic><sup>+</sup> reversions. Data from at least three independent experiments ± SD. Statistical analysis was by two-tailed Students T-test, p<italic>&gt;0.05</italic> = not significant (<italic>ns</italic>). (<bold>C</bold>) Polymerase bias graph calculated using the ratio of polymerase usage across both strands at the <italic>RTS1</italic> RFB In cells expressing <italic>rtf1</italic>Δ<italic>int</italic> and either with or deleted for <italic>rtf2</italic><sup>+</sup>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78554-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Intronless <italic>rtf1</italic> raw Pu-seq traces<italic>.</italic></title><p><italic>(</italic><bold>A</bold>) Polymerase-usage sequencing at active <italic>RTS1</italic> RFB (<italic>RTS1</italic> ON) in an <italic>rtf1</italic>Δ<italic>int</italic> background with either <italic>rtf2</italic><sup>+</sup> (left panel) or <italic>rtf2</italic>Δ (right panel) backgrounds. Top panel shows the ratio of Polymerase ε (red) and Polymerase ẟ (blue) for both the top and bottom strand. Bottom panel shows the polymerase bias calculated using the ratio of polymerase usage across both strands at the <italic>RTS1</italic> RFB from the samples traces above (orange) in comparison to a WT <italic>rtf1</italic><sup>+</sup> background with either <italic>rtf2</italic><sup>+</sup> (black) or <italic>rtf2</italic>Δ (blue).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78554-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Rtf1 structural predictions.</title><p>(<bold>A</bold>) Left: Secondary structure cartoon for an AlphaFold2 (AF2) model of <italic>S. pombe</italic> Rtf2, coloured according to its predicted domain composition. Right: A DALI search using the AF2 model, indicated a high degree of similarity to the X-ray crystal structure of <italic>S. pombe</italic> Reb1 in complex (coloured grey) with a cognate Ter3 terminator DNA binding site (orange/cyan). (<bold>B</bold>) Left: AF2 model for the wildtype (top) and splice variant (bottom) of <italic>S. pombe</italic> Rtf2. Wildtype residues are coloured green and the inserted amino acids are coloured yellow. These are predicted to extend the H1 helix, yet preserve the overall fold of the MybAD-2 domain. Right: The two models are also shown coloured according to AF2 pLDDT confidence score.</p><p><supplementary-material id="fig4s2sdata1"><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78554-fig4-figsupp2-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78554-fig4-figsupp2-v2.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Rtf1 with the amino acid sequence from a non-excisable intron 2 does not increase slippage.</title><p>(<bold>A</bold>) Schematic of <italic>rtf1</italic>+ (grey) and <italic>rtf1-2NE</italic> (orange), where intron 2 is modified to encode the same amino acid sequence but to be non-excisable (red line). (<bold>B</bold>) Replication fork slippage events scored as the frequency of <italic>ura4</italic><sup>+</sup> reversions. Data from at least three independent experiments ± SD. Statistical analysis was by two-tailed Students T-test. (<bold>C</bold>) Whole cell extract of <italic>V5-rtf1</italic> and V5-rtf1 intron2NE containing cells in WT and <italic>rtf2</italic>Δ background probed with indicated antibody. Tubulin is shown as a loading control.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78554-fig4-figsupp3-v2.tif"/></fig><fig id="fig4s4" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 4.</label><caption><title>Uncropped blots for <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78554-fig4-figsupp4-v2.tif"/></fig></fig-group><p>To confirm the increased mutagenicity downstream of <italic>RTS1</italic> in <italic>rtf2</italic>Δ <italic>rtf1</italic>Δ<italic>int</italic> cells is due to <italic>rtf2</italic><sup>+</sup> levels of RFB activity and replication fork restart, <italic>rtf1</italic>Δ<italic>int</italic> was also analysed by Pu-seq (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). In both <italic>rtf2<sup>+</sup></italic> and <italic>rtf2</italic>Δ backgrounds, the presence of <italic>rtf1</italic>Δ<italic>int</italic> resulted in the same high levels of Polδ bias downstream of active <italic>RTS1</italic>, which are equivalent to levels seen for <italic>rtf1<sup>+</sup>, rtf2<sup>+</sup> +TS1</italic> ON (c.f. <xref ref-type="fig" rid="fig1">Figure 1B</xref>). Raw Pu-seq traces also clearly show Polδ to be the predominant polymerase used in both the top and bottom strands downstream of <italic>RTS1</italic> (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). This demonstrates that the presence of Rtf2 is essential for the correct splicing of Rtf1 to allow efficient barrier activity at <italic>RTS1</italic>.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The finding that the removal of human RTF2 from stalled replication forks is important to allow replication restart and maintain genome stability (<xref ref-type="bibr" rid="bib17">Kottemann et al., 2018</xref>) led us to investigate the function of <italic>S. pombe</italic> Rtf2 in more detail. The Rtf2 protein was originally identified as having the role of enhancing the blocking capacity of the <italic>RTS1</italic> RFB in <italic>S. pombe</italic> (<xref ref-type="bibr" rid="bib7">Codlin and Dalgaard, 2003</xref>). 2D gel analysis of replicating plasmids containing <italic>RTS1</italic> revealed a reduced pausing signal when cells were deleted for <italic>rtf2</italic>. A further study identified a visible increase in large Y-intermediates that were dependent on the Srs2 helicase (<xref ref-type="bibr" rid="bib13">Inagawa et al., 2009</xref>). This was interpreted as Rtf2 acting downstream of Rtf1 to convert replication barrier activity at the <italic>RTS1</italic> locus into a replication termination site.</p><p>Here, we confirm that the loss of Rtf2 indeed results in a decrease in replication fork arrest and restart by RDR at the <italic>RTS1</italic> RFB. However, we clearly identify Rtf2 as interacting with splicing factors and demonstrate increased intron retention in a subset of transcripts when <italic>rtf2</italic> is deleted. Importantly, we found that intron 2 of Rft1, a Myb-domain binding protein required for <italic>RTS1</italic> barrier activity (<xref ref-type="bibr" rid="bib12">Eydmann et al., 2008</xref>), is not spliced in <italic>rtf2</italic>Δ cells and this results in an Rtf1 protein that contains a 15 amino acid insertion between residues 202–203. Rtf1 contains 5 domains that resemble Myb/SANT domains. A DALI search of an AlphaFold2 model of Rtf1 indicates a high degree of similarity with the crystal structure of <italic>S. pombe</italic> Reb1, which promotes replication pausing within the rDNA spacer region (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). The 15 amino acid insertion is unlikely to disrupt DNA binding directly, but appears to extend a helix that, based on our observations, renders the resulting Rtf1 protein dysfunctional (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Replacing the genomic <italic>rtf1</italic> gene with an intronless copy fully rescued the <italic>rft2</italic>Δ-dependent defect in fork arrest at <italic>RTS1</italic>, clearly demonstrating that Rft2 acts upstream of Rtf1 to allow the correct splicing of the <italic>rft1</italic> mRNA and thus the production of fully functional Rtf1 protein. We also confirmed that expression of an intron-less <italic>rtf1</italic> gene that encodes the same additional 15 amino acids between residues 202–203 (Rtf1 intron2NE) does not provoke increased replication slippage downstream of <italic>RTS1</italic> (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>), indicating that this protein is indeed dysfunctional.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Mis-splicing of <italic>rtf1</italic> mRNA in <italic>rtf2</italic>Δ cells results in reduced <italic>RTS1</italic> RFB Activity.</title><p><italic>Left panel</italic>: In wildtype cells Rtf2 is present and allows for the correct splicing of <italic>rtf1</italic> mRNA and the production of functional Rtf1 protein. This results in replication fork stalling at <italic>RTS1</italic> and RDR, which produces non-canonical δ/δ replication forks. <italic>Right panel</italic>: In <italic>rtf2</italic>Δ cells, <italic>rtf1</italic> mRNA is mis-spliced resulting in retention of intron 2. This produces an Rtf1 protein less capable of blocking replication forks at <italic>RTS1</italic> manifesting as some forks able to bypass <italic>RTS1</italic> unhindered and continue as canonical replication forks. A small portion of forks are still arrested and restart by RDR resulting in a small proportion of non-canonical δ/δ replication.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78554-fig5-v2.tif"/></fig><p>Using 2D gel analysis of plasmids containing various deletion constructs of <italic>RTS1</italic>, previous work suggested Rtf2-dependent enhanced blocking capacity at <italic>RTS1</italic> functions via an interaction with Region A of the <italic>RTS1</italic> sequence (<xref ref-type="bibr" rid="bib7">Codlin and Dalgaard, 2003</xref>). In our genomic <italic>RTS1</italic> system, we showed that deletion of Region A (<italic>RTS1_A</italic>Δ), does not affect the levels of non-canonical (δ/δ) replication forks or the levels of replication fork slippage downstream of active <italic>RTS1</italic> (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Therefore, these results contrast with the previous finding and demonstrate that region A of <italic>RTS1</italic> is dispensable for the efficiency of barrier activity and not to be the site of Rtf2 interaction.</p><p>RTF2 in human cells has been shown to be enriched at nascent chromatin (<xref ref-type="bibr" rid="bib11">Dungrawala et al., 2015</xref>; <xref ref-type="bibr" rid="bib17">Kottemann et al., 2018</xref>). However, we see no evidence to suggest that <italic>S. pombe</italic> Rtf2 is associated with the replication fork from our biotin proximity labelling experiments: Mass spectrometry analysis of proteins within close proximity to Rtf2 did not identify any replication associated factors (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). The studies in human cells specifically enriched for nascent chromatin and it is therefore possible that this allowed higher sensitivity for Rtf2 enrichment when compared to our TurboID experiments. Of note, a previous study <xref ref-type="bibr" rid="bib13">Inagawa et al., 2009</xref> found Rtf2 to co-precipitate with <italic>S. pombe</italic> Pcn1 (PCNA). We did not find any evidence that Pcn1 was enriched in our TurboID MS data. It is possible that a Pcn1:Rtf2 interaction does occur, but is very transient and only visualised in the previous study due to the use of overexpression plasmids.</p><p>Rtf2 is an abundant protein that is predicted to contain a RING motif similar to that found in the E3 SUMO ligases Pli1 and Nse2 in <italic>S. pombe</italic> (<xref ref-type="bibr" rid="bib41">Watts et al., 2007</xref>) and potentially related to RING domains of ubiquitin E3 ligases. Furthermore, deletion of <italic>pmt3</italic> (<italic>S. pombe</italic> SUMO) has been reported to result in a similar decrease in replication fork stalling at <italic>RTS1</italic> as <italic>rtf2</italic>Δ (<xref ref-type="bibr" rid="bib13">Inagawa et al., 2009</xref>), leading to speculation that Rtf2 acts at the <italic>RTS1</italic> stall site to SUMO modify replication factors. However, it has also been shown that ubiquitylation and sumoylation of splicing factors are important to maintain efficient splicing within a cell (<xref ref-type="bibr" rid="bib31">Pozzi et al., 2017</xref>) and therefore it is also conceivable that the efficient splicing of <italic>rtf1</italic> intron 2<italic>,</italic> as well as other introns, is dependent on either sumoylation and/or ubiquitylation (<xref ref-type="bibr" rid="bib32">Pozzi et al., 2018</xref>) of splicing factors by Rtf2. The balance of evidence suggests that Rtf2 has evolved a new function(s) in human cells to modulate replication fork restart: we are unable to identify any evidence that Rtf2 associates with replication proteins, <italic>rtf2</italic> deletion does not directly affect <italic>RTS1</italic>-dependent fork arrest or subsequent restart by RDR; <italic>rtf2</italic> deletion cells are not sensitive to the replication inhibitor HU. Furthermore, in human cells RTF2 is actively degraded via the DDI1/2 proteasomal shuttle system to regulate its activity at stalled forks. In <italic>S. pombe,</italic> we saw no evidence that the DDI1/2 homolog, Mud1, is influencing Rtf2 stability or the response to HU treatment.</p><p>Rtf2 has also been identified in <italic>Arabidopsis thaliana</italic> as an essential protein that contains an additional non-conserved N-terminal extension (<xref ref-type="bibr" rid="bib34">Sasaki et al., 2015</xref>). Mass spectrometry to identify <italic>At</italic>Rtf2 interacting proteins revealed proteins involved in mRNA splicing, RNA binding and metabolism, as well as DNA binding and ribosomal proteins. Mass spectrometry for proteins interacting with <italic>At</italic>Rtf2 truncated for the non-conserved N-terminal domain identified many of the same proteins, indicating the interactions and their specificity to the conserved core of RTF2 are likely to be conserved between <italic>S. pombe</italic> and humans. Furthermore, the cDNA-Seq we conducted identified a subset of introns that were inefficiently spliced in <italic>rtf2</italic>Δ cells (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). This is consistent with the study in <italic>A. thaliana</italic>, which also detected intron retention defects when <italic>AtRTF2</italic> was deleted (<xref ref-type="bibr" rid="bib34">Sasaki et al., 2015</xref>). Interestingly, a genome wide screen in <italic>S. pombe</italic> for factors affecting mRNA splicing similarly identified deletion of <italic>rtf2</italic> to result in intron retention defects (<xref ref-type="bibr" rid="bib19">Larochelle et al., 2019</xref>), supporting our cDNA-Seq results (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Whether Rtf2 acts directly as a splicing factor or indirectly effects spliceosome function remains to be elucidated.</p><p>Rtf2 is a conserved protein that affects splicing in fission yeast and plants and is likely to affect splicing in humans. In <italic>S. pombe,</italic> the major phenotype that has been observed relates to replication fork arrest at the <italic>RTS1</italic> barrier, but other biological processes (for example a cellular response to MMS in fission yeast - <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>) are likely to be affected by inefficient spicing of other proteins. It is also likely that other pathways are directly influenced by Rft2 function, as appears to be the case in human cells (<xref ref-type="bibr" rid="bib17">Kottemann et al., 2018</xref>; <xref ref-type="bibr" rid="bib36">Suo et al., 2020</xref>). Recently, Rtf2 has been implicated in a number of additional physiological functions and pathologies including restriction of viral infection (<xref ref-type="bibr" rid="bib5">Chia et al., 2020</xref>) and a possible causal factor for Alzheimer’s disease in humans (<xref ref-type="bibr" rid="bib42">Wingo et al., 2021</xref>; <xref ref-type="bibr" rid="bib29">Ou et al., 2021</xref>). Alzheimer’s has previously been associated with differential splicing patterns (<xref ref-type="bibr" rid="bib33">Raj et al., 2018</xref>) raising the possibility that the mis-splicing observed in Alzheimer’s patients could be connected to changes in RTF2 protein function in these patients. This needs to be investigated further but could provide a better understanding of the disease’s progression.</p><p>In summary, we identify <italic>S. pombe</italic> Rtf2 as a key factor for the efficient splicing of a subset of introns and demonstrate that this explains the effects of <italic>rtf2</italic>Δ at the site-specific replication fork barrier <italic>RTS1</italic> (<xref ref-type="fig" rid="fig5">Figure 5</xref>).</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-HA<break/>(mouse monoclonal)</td><td align="left" valign="bottom">SantaCruz</td><td align="left" valign="bottom">SC-7392</td><td align="left" valign="bottom">IB(1:1000)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Anti-V5<break/>(mouse monoclonal)</td><td align="left" valign="bottom">Bio-Rad</td><td align="left" valign="bottom">MCA1360</td><td align="left" valign="bottom">IB(1:5000)</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Anti-Tubulin<break/>(mouse monoclonal)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">T5168</td><td align="left" valign="bottom">IB(1:20,000)</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Anti-Cdc2<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">SantaCruz</td><td align="left" valign="bottom">SC-53</td><td align="left" valign="bottom">IB(1:5000)</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">NEBuilder HiFi DNA Assembly Master Mix</td><td align="left" valign="bottom">NEB</td><td align="left" valign="bottom">E2621L</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">MasterPure Yeast RNA Extraction Kit</td><td align="left" valign="bottom">Biosearch Technologies</td><td align="left" valign="bottom">MPY03100</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">NEBNext Poly(A) mRNA Magnetic Isolation Module</td><td align="left" valign="bottom">NEB</td><td align="left" valign="bottom">E7490</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RevertAid Firest Strand cDNA Synthesis Kit</td><td align="left" valign="bottom">Thermo</td><td align="left" valign="bottom">K1621</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Nanopore Direct cDNA Sequencing Kit</td><td align="left" valign="bottom">Oxford Nanopore</td><td align="left" valign="bottom">SQK-DCS109</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">MiniION sequencing device</td><td align="left" valign="bottom">Oxford Nanopore</td><td align="left" valign="bottom">MIN-101B</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">MiniION Flow Cell</td><td align="left" valign="bottom">Oxford Nanopore</td><td align="left" valign="bottom">FLO-MIN106D</td><td align="left" valign="bottom">Chemistry type (R9.4.1)</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Microcon Y M-30 Filter Unit</td><td align="left" valign="bottom">Millipore</td><td align="char" char="." valign="bottom">42410<break/>MRCF0R030</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">SPE Column (C18 resin)</td><td align="left" valign="bottom">Pierce</td><td align="char" char="." valign="bottom">89870</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="char" char="hyphen" valign="bottom">3-BrB-PP1</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab143756</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Bowtie2</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22388286/">22388286</ext-link></td><td align="left" valign="bottom">v2.4.4</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Puseq_app</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/26492137/">26492137</ext-link></td><td align="left" valign="bottom">v1</td><td align="left" valign="bottom">R script</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MaxQuant</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27809316/">27809316</ext-link></td><td align="left" valign="bottom">v1.6.12.0</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Perseus</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27348712/">27348712</ext-link></td><td align="left" valign="bottom">v1.6.15.0</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Minimap2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib21">Li, 2018</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GffCompare</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib30">Pertea and Pertea, 2020</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Strain construction</title><p>Strains used in this study are listed in <xref ref-type="table" rid="table1">Table 1</xref> and are available from the authors upon request. Standard yeast genetic techniques and media were used as previously described (<xref ref-type="bibr" rid="bib27">Moreno et al., 1991</xref>). All liquid cultures were grown in YES media at 30 °C unless otherwise stated. Cells were plated onto YEA plus the required selective agents during strain construction. Deletion of region A of <italic>RTS1</italic> was conducted using overlapping primers lacking region A (A30/A31; see <xref ref-type="table" rid="table2">Table 2</xref>) to amplify the pAW8-<italic>RTS1-ura4</italic> plasmid to create pAW8-<italic>RTS1_A</italic>Δ-<italic>ura4</italic>. This plasmid was then transformed into the relevant strain to introduce RTS1_<italic>A</italic>Δ via the recombination mediated cassette exchange (RMCE) method <xref ref-type="bibr" rid="bib40">Watson et al., 2008</xref> followed by genetic crosses to create the final strains BAY237-BAY242. To create the <italic>RTS1</italic> slippage assay strains, a fragment containing a region of <italic>ura4</italic> containing the 20 bp tandem repeat of <italic>ura4-sd20</italic> (<xref ref-type="bibr" rid="bib14">Iraqui et al., 2012</xref>) was synthesised by Eurofins and digested with <italic>Stu</italic>I and <italic>Dra</italic>III for insertion into pAW8-RTS1-ura4 or pAW8-RTS1_AΔ-ura4 plasmids to create the plasmids pAW8-RTS1-ura4-sd20 or pAW8-RTS1_AΔ-ura4-sd20. These plasmids were then transformed into the relevant strain to introduce the constructs via the recombination mediated cassette exchange (RMCE) method (<xref ref-type="bibr" rid="bib40">Watson et al., 2008</xref>) to create the strains BAY144 and BAY249, respectively.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Strain list.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Strain</th><th align="left" valign="bottom">Genotype</th><th align="left" valign="bottom">Reference</th></tr></thead><tbody><tr><td align="left" valign="bottom"><bold>BAY119</bold></td><td align="left" valign="bottom"><italic>II::RTS1-ura4-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rnh201</italic>Δ<italic>::KAN, rtf2</italic>Δ<italic>::NAT, cdc6L591G, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY120</bold></td><td align="left" valign="bottom"><italic>II::RTS1-ura4-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rnh201</italic>Δ<italic>::KAN, rtf2</italic>Δ<italic>::NAT, rtf1</italic>Δ<italic>::HYG, cdc6L591G, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY121</bold></td><td align="left" valign="bottom"><italic>II::RTS1-ura4-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rnh201</italic>Δ<italic>::KAN, rtf2</italic>Δ<italic>::NAT, cdc20_M630F, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY122</bold></td><td align="left" valign="bottom"><italic>II::RTS1-ura4-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rnh201</italic>Δ<italic>::KAN, rtf2</italic>Δ<italic>::NAT, rtf1</italic>Δ<italic>::HYG, cdc20_M630F, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY123</bold></td><td align="left" valign="bottom"><italic>II::RTS1-ura4-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rnh201</italic>Δ<italic>::KAN, rtf1</italic>Δ<italic>::HYG, cdc20M630F, ade6-704, leu1-32, ura4-d18</italic></td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib28">Naiman et al., 2021</xref></td></tr><tr><td align="left" valign="bottom"><bold>BAY124</bold></td><td align="left" valign="bottom"><italic>II::RTS1-ura4-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rnh201</italic>Δ<italic>::KAN, cdc20M630F, ade6-704, leu1-32, ura4-d18</italic></td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib28">Naiman et al., 2021</xref></td></tr><tr><td align="left" valign="bottom"><bold>BAY125</bold></td><td align="left" valign="bottom"><italic>II: RTS1-ura4-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rnh201</italic>Δ<italic>::KAN, rtf1</italic>Δ<italic>::HYG, cdc6L591G, ade6-704, leu1-32, ura4-d18</italic></td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib28">Naiman et al., 2021</xref></td></tr><tr><td align="left" valign="bottom"><bold>BAY126</bold></td><td align="left" valign="bottom"><italic>II::RTS1-ura4-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rnh201</italic>Δ<italic>::KAN, cdc6L591G, ade6-704, leu1-32, ura4-d18</italic></td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib28">Naiman et al., 2021</xref></td></tr><tr><td align="left" valign="bottom"><bold>BAY144</bold></td><td align="left" valign="bottom"><italic>II::Rura4sd20-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rtf1</italic>Δ<italic>::NAT, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY146</bold></td><td align="left" valign="bottom"><italic>II::Rura4sd20-10xrRFB, RTS1</italic>Δ<italic>::Phleo, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY176</bold></td><td align="left" valign="bottom"><italic>II::Rura4sd20-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rtf2</italic>Δ<italic>::NAT, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY182</bold></td><td align="left" valign="bottom"><italic>rtf2-3HA:KAN, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY237</bold></td><td align="left" valign="bottom"><italic>II::RTS1_A</italic>Δ<italic>-ura4-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rnh201</italic>Δ<italic>::KAN, cdc6L591G, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY238</bold></td><td align="left" valign="bottom"><italic>II::RTS1_A</italic>Δ<italic>-ura4-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rnh201</italic>Δ<italic>::KAN, cdc20M630F, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY239</bold></td><td align="left" valign="bottom"><italic>II::RTS1_A</italic>Δ<italic>-ura4-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rnh201</italic>Δ<italic>::KAN, rtf1</italic>Δ<italic>::HYG, cdc6L591G, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY240</bold></td><td align="left" valign="bottom"><italic>II::RTS1_A</italic>Δ<italic>-ura4-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rnh201</italic>Δ<italic>::KAN, rtf1</italic>Δ<italic>::HYG, cdc20M630F, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY241</bold></td><td align="left" valign="bottom"><italic>II::RTS1_A</italic>Δ<italic>-ura4-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rnh201</italic>Δ<italic>::KAN, rtf2</italic>Δ<italic>::NAT, cdc20_M630F, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY242</bold></td><td align="left" valign="bottom"><italic>II::RTS1_A</italic>Δ<italic>-ura4-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rnh201</italic>Δ<italic>::KAN, rtf2</italic>Δ<italic>::NAT, cdc6L591G, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY246</bold></td><td align="left" valign="bottom"><italic>rtf2-3HA:TurboID:KAN, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY249</bold></td><td align="left" valign="bottom"><italic>II::RTS1_A</italic>Δ<italic>ura4sd20-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rtf1</italic>Δ<italic>::HYG, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY251</bold></td><td align="left" valign="bottom"><italic>II::RTS1_A</italic>Δ<italic>ura4sd20-10xrRFB, RTS1</italic>Δ<italic>::Phleo, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY252</bold></td><td align="left" valign="bottom"><italic>II::RTS1_A</italic>Δ<italic>ura4sd20-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rtf2</italic>Δ<italic>::NAT, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY253</bold></td><td align="left" valign="bottom"><italic>II::RTS1_A</italic>Δ<italic>ura4sd20-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rtf2</italic>Δ<italic>::NAT, rtf1</italic>Δ<italic>::HYG, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY267</bold></td><td align="left" valign="bottom"><italic>rtf2-3HA-TurboID:KAN, cdc2asM17, II::RTS1-ura4-10xrRFB, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY268</bold></td><td align="left" valign="bottom"><italic>mud1</italic>Δ<italic>::HYG, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY269</bold></td><td align="left" valign="bottom"><italic>mud1</italic>Δ<italic>::HYG, rtf2-3HA:KAN, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY273</bold></td><td align="left" valign="bottom"><italic>mud1</italic>Δ<italic>::HYG, rtf2</italic>Δ<italic>::NAT, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY278</bold></td><td align="left" valign="bottom"><italic>II::RTS1-ura4sd20-10xrRFB, rtf1</italic>Δ<italic>int:HYG, RTS</italic>Δ<italic>::Phleo, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY279</bold></td><td align="left" valign="bottom"><italic>II::RTS1-ura4sd20-10xrRFB, rtf1</italic>Δ<italic>int:HYG, RTS</italic>Δ<italic>::Phleo, rtf2</italic>Δ<italic>::NAT, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY280</bold></td><td align="left" valign="bottom"><italic>II::RTS1-ura4-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rtf1</italic>Δ<italic>int:HYG, rnh201</italic>Δ<italic>::KAN, cdc20M630F, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY281</bold></td><td align="left" valign="bottom"><italic>II::RTS1-ura4-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rtf1</italic>Δ<italic>int:HYG, rtf2</italic>Δ<italic>::NAT, rnh201</italic>Δ<italic>::KAN, cdc20M630F, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY282</bold></td><td align="left" valign="bottom"><italic>II::RTS1-ura4-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rtf1</italic>Δ<italic>int:HYG, rnh201</italic>Δ<italic>::KAN, cdc6L591G, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY283</bold></td><td align="left" valign="bottom"><italic>II::RTS1-ura4-10xrRFB, RTS1</italic>Δ<italic>::Phleo, rtf1</italic>Δ<italic>int:HYG, rtf2</italic>Δ<italic>::NAT, rnh201</italic>Δ<italic>::KAN, cdc6L591G, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY285</bold></td><td align="left" valign="bottom"><italic>V5-rtf1, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>BAY286</bold></td><td align="left" valign="bottom"><italic>V5-rtf1, rtf2</italic>Δ<italic>::NAT, ade6-704, leu1-32, ura4-d18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>AW2280</bold></td><td align="left" valign="bottom"><italic>rtf1 intron2NE-hphMX6, ade6-704, leu1-32, ura4D18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>AW2284</bold></td><td align="left" valign="bottom"><italic>V5-rtf1 intron2NE-hphMX6, ade6-704, leu1-32, ura4D18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>AW2309</bold></td><td align="left" valign="bottom"><italic>V5-rtf1 intron2NE-hphMX6, rtf2::natMX6, ade6-704, leu1-32, ura4D18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>AW2324</bold></td><td align="left" valign="bottom"><italic>II:Rura4sd20-10XrRFB, RTS1::pleoMX6, rtf1 intron2NE:hphMX6, ade6-704, leu1-32, ura4D18</italic></td><td align="left" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><bold>AW2327</bold></td><td align="left" valign="bottom"><italic>II:Rura4sd20-10XrRFB, RTS1::pleoMX6, rtf1 intron2NE:hphMX6, rtf2::natMX6, ade6-704, leu1-32, ura4D18</italic></td><td align="left" valign="bottom">This study</td></tr></tbody></table></table-wrap><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Primer list.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Name</th><th align="left" valign="bottom">Sequence</th></tr></thead><tbody><tr><td align="left" valign="bottom">A30</td><td align="left" valign="bottom"><named-content content-type="sequence">GGAGGTTGAGTGTGGGACGTTTCTGCCATACCCTTTTTAAGT</named-content></td></tr><tr><td align="left" valign="bottom">A31</td><td align="left" valign="bottom"><named-content content-type="sequence">GGTATGGCAGAAACGTCCCACACTCAACCTCCCAAT</named-content></td></tr><tr><td align="left" valign="bottom">P1</td><td align="left" valign="bottom"><named-content content-type="sequence">ATTATACGAAGTTATGCATGGTTTGATATGAGGCAGATAC</named-content></td></tr><tr><td align="left" valign="bottom">P2</td><td align="left" valign="bottom"><named-content content-type="sequence">TTCCTTGCATAATAATGTTCACTTGTCTGAAG</named-content></td></tr><tr><td align="left" valign="bottom">P3</td><td align="left" valign="bottom"><named-content content-type="sequence">GAACATTATTATGCAAGGAAAAAACAATTTAAG</named-content></td></tr><tr><td align="left" valign="bottom">P4</td><td align="left" valign="bottom"><named-content content-type="sequence">CGCTGGCCGGCTAGCATAAATCATCGGC</named-content></td></tr><tr><td align="left" valign="bottom">P5</td><td align="left" valign="bottom"><named-content content-type="sequence">TTTATGCTAGCCGGCCAGCGACATGGAG</named-content></td></tr><tr><td align="left" valign="bottom">P6</td><td align="left" valign="bottom"><named-content content-type="sequence">ATACCATATACGAAGTTATACGACAGCAGTATAGCGACCAG</named-content></td></tr><tr><td align="left" valign="bottom">P7</td><td align="left" valign="bottom"><named-content content-type="sequence">GGAGCAAACGACATTATCAC</named-content></td></tr><tr><td align="left" valign="bottom">P8</td><td align="left" valign="bottom"><named-content content-type="sequence">CATCACGATGGTTATCAGAC</named-content></td></tr><tr><td align="left" valign="bottom">P9</td><td align="left" valign="bottom"><named-content content-type="sequence">CTATGGACAGCAGATGCTTG</named-content></td></tr><tr><td align="left" valign="bottom">P10</td><td align="left" valign="bottom"><named-content content-type="sequence">GCGGTGTAAGAATCATGTAA</named-content></td></tr><tr><td align="left" valign="bottom">P11</td><td align="left" valign="bottom"><named-content content-type="sequence">GAAGTTATGCATGCTCTACCCGTATGATGTTCCGGA</named-content></td></tr><tr><td align="left" valign="bottom">P12</td><td align="left" valign="bottom"><named-content content-type="sequence">AGCTGCGGCGCGCCTCACTTTTCGGCAGACCGCAGAC</named-content></td></tr></tbody></table></table-wrap><p>The BirA<sup>TbID</sup> C-terminally tagged Rtf2 was constructed via construction of plasmid pAW8-3HA-TurboID:KAN. A 3HA-BirA<sup>TbID</sup> encoding sequence was amplified using P11/P12 primers and the PCR fragment and pAW8 plasmid digested with <italic>Sph</italic>I/<italic>Asc</italic>I and ligated. The resulting plasmid, pAW8-3HA-TurboID:KAN was transformed into an <italic>rtf2</italic> C-terminal tagging base strain to create BAY246 via the RMCE method (<xref ref-type="bibr" rid="bib40">Watson et al., 2008</xref>). The same method is used to C-terminally tag Rtf2 with 3 HA alone, via transformation of pAW8-3HA:KAN to create BAY182.</p><p>To create <italic>rtf1</italic>Δ<italic>int</italic> strains, NEBuilder HiFi DNA Assembly Master Mix (Cat #E2621L) was used to combine <italic>rtf1</italic> 5’UTR (P1/P2) with <italic>rtf1</italic> CDS (synthesised by Eurofins, P3/P4) and a hygromycin marker cassette (P5/P6) was amplified with the indicated primers and cloned into <italic>Spe</italic>I/<italic>Sph</italic>I digested pAW8 to create pAW8-rtf1-CDS:hphMX6. The construct was then amplified and transformed into cells via linear fragment transformation.</p><p>For <italic>rtf1intron2NE</italic> strains, DNA fragments containing 400 bp of <italic>rtf1</italic> 5’UTR and the <italic>rtf1</italic> coding sequence with all introns removed except for intron 2 were synthesised (Integrated DNA technologies). Intron 2 3' (AG) splice site was mutated (to AA). An identical DNA fragment was synthesised but the <italic>rtf1</italic> coding sequence included an N-terminal V5 tag. The V5 tag and <italic>rtf1</italic> sequence were separated by a small amino acid linker (Gly-Ala-Gly-Ala-Gly-Ala). The fragments were cloned into pAW8-hphMX6 restricted with <italic>Sph</italic>I and <italic>Bgl</italic>II to create pAW8-rtf1intron2NE-hphMX6 and pAW8-V5-rtf1intron2NE-hphMX6, respectively. The constructs were removed by restriction with <italic>Sph</italic>I and <italic>Pme</italic>I, gel isolated and transformed into cells via linear fragment transformation.</p><p>N-terminal tagging of Rtf1 with the V5 tag was conducted by first introducing the <italic>ura4</italic> gene between <italic>rtf1</italic> 5’UTR and exon 1 and transformation to create a strain containing <italic>ura4:rtf1</italic>. A synthesised DNA sequence containing 400 bp of the 5’UTR followed by the V5 tag, then a small amino acid linker (Gly-Ala-Gly-Ala-Gly-Ala) and finally 400 bp of exon 1 of <italic>rtf1</italic> was digested with <italic>Sal</italic>I and ligated into <italic>Sal</italic>I digested pAW1 plasmid to create pAW1-V5-rtf1. This fragment was then amplified and the linear fragment transformed into the <italic>ura4:rtf1</italic> containing strain, replacing <italic>ura4</italic> with the V5 tag to create BAY285.</p></sec><sec id="s4-2"><title>Replication fork slippage assay</title><p><italic>S. pombe</italic> strains containing the <italic>RTS1-ura4-sd20</italic> construct were grown in 10 ml YE containing 1 mg/ml 5-FOA overnight at 30 °C. Cells were washed in 1 ml 5-FOA-free YE and resuspended into 10 ml fresh YE at a density of 2x10<sup>6</sup> cells/ml. Cells were grown for two cell cycles before pelleting and re-suspending in 1 ml ddH<sub>2</sub>O. A total of 100 μl of cells were then plated in appropriate dilutions onto 2 YEA plates and 2 YNBA plates containing appropriate amino acids minus uracil. Plates were then incubated at 30 °C for 3–5 days. The numbers of colonies were counted and the average mean was taken between each of the two plates. Reversion frequency of Ura<sup>+</sup> colonies was then calculated (<xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref>), taking into consideration the dilutions plated between YEA plates and YNBA plates lacking uracil.</p></sec><sec id="s4-3"><title>Protein extraction and western blotting</title><p><italic>S. pombe</italic> strains grown to logarithmic phase were collected and 5x10<sup>7</sup> cells were washed and re-suspended in 200 μl ml 20% trichloroacetic acid (TCA). Samples treated with cycloheximide to block protein synthesis were treated at a final concentration of 100 µg/ml before collection at the indicated time points after addition of drug. Cells were then lysed using glass beads and a Ribolyser (Fast Prep Hybaid, Cat #FP120) for 3x30 s at 6.5 m/s. Glass beads were removed and the pellet re-suspended in 200 μl 1 X Protein Loading Buffer (250 mM Tris pH 6.8, 8% SDS, 20% glycerol, 20% β-mercaptoethanol, and 0.4% bromophenol blue) and boiled at 95 °C for 10 min.</p><p>Proteins were separated using SDS-PAGE followed by transfer onto a nitrocellulose membrane (Amersham, Cat #45004003) using the Invitrogen XCell II Blot Module. Membranes were then blocked in 5% Milk (dissolved in PBST (PBS + 0.1% (v/v) Tween)) for 1 hr before incubation with the relevant primary antibody diluted in 5% Milk PBST overnight at 4 °C. (anti-HA SantaCruz SC-7392, 1:1000; anti-V5 Bio-Rad MCA1360, 1:5000; anti-Tubulin Sigma T5168, 1:20,000; anti-Cdc2 SantaCruz SC-53, 1:5000). Membranes were then washed 3 x with PBST for 5 min each at room temperature before incubation with a horse radish peroxidase-conjugated secondary antibody (HA/V5/Tubulin: Rabbit anti-mouse Dako P0161. Cdc2: swine anti-rabbit Dako P0217) at room temperature for 1 hr followed by a further 3 x PBST washes. Proteins were detected using the Western Lightning Plus-ECL chemiluminescent substrate (Perkin Elmer, Cat #NEL103001EA) and autoradiograph film processed in an X-ray film developer.</p></sec><sec id="s4-4"><title>Polymerase-usage sequencing</title><p>The published protocol was used for library generation and the published pipeline (that uses Bowtie2 to align sequence files and convert mapped reads to count files) was followed (<xref ref-type="bibr" rid="bib16">Keszthelyi et al., 2015</xref>). Analysis of the read counts was conducted using the published R script to obtain polymerase usage and polymerase bias information (<xref ref-type="bibr" rid="bib16">Keszthelyi et al., 2015</xref>).</p></sec><sec id="s4-5"><title>Nanopore direct cDNA-sequencing</title><p>Total RNA was extracted from 10 ml of logarithmically grown <italic>S. pombe</italic> cells using the MasterPure Yeast RNA Extraction Kit (Cat #MPY03100). PolyA-mRNA was isolated using NEBNext Poly(A) mRNA Magnetic Isolation Module (Cat #E7490). Purified PolyA-mRNA was then used to prepare cDNA sequencing libraries using the Nanopore Direct cDNA Sequencing Kit according to manufacturer’s instructions (Cat #SQK-DCS109). The cDNA libraries were sequenced using the MinION sequencing device (Cat #MIN-101B) and associated flow cells (Cat #FLO-MIN106D). Sequenced reads were processed using the <ext-link ext-link-type="uri" xlink:href="https://github.com/epi2me-labs/wf-isoforms">Nanopore Technology Reference Isoforms pipeline</ext-link> (<xref ref-type="bibr" rid="bib43">Wright et al., 2022</xref>). This pipeline sorts and aligns reads to the reference genome producing alignment BAM files and consensus transcript annotation GFF files. Calculations of intron retention (IR) were based on an alignment threshold of&gt;70% for reads to each intronic and flanking exonic sequence. An intron was only counted as an IR event if the subsequent exonic sequence was also present. It should be noted that this analysis does not necessarily identify all mis-splicing events.</p><p>Testing intron retention levels via PCR amplification was conducted using RevertAid First Strand cDNA Synthesis Kit (Thermo, Cat #K1621) to create cDNA from mRNA. Amplification of <italic>rtf1</italic> intron 2 was carried out using primer pair P7/P8, and intron 6 amplified using P9/P10. PCR product were purified using a QIAquick PCR Purification Kit (Qiagen, Cat #28104) before running on a 2% agarose gel.</p></sec><sec id="s4-6"><title>Cell synchronisation</title><p><italic>S. pombe</italic> strains containing the <italic>cdc2asM17</italic> ATP-analogue sensitive allele (<xref ref-type="bibr" rid="bib35">Singh et al., 2021</xref>) were grown O/N at 28 °C. Once cell density reached 2.5x10<sup>6</sup> cells/ml, 1:1000 volume of 3-BrB-PP1 (2 mM) was added to the culture and incubated at 28 °C for a further 3 hr to synchronise in G2. Cultures were then filtered using a vacuum flask filter unit. Cells collected on the filter paper (0.22 μm, Millipore, Cat #N8645) were then washed three times by addition of fresh YE media and filtration. The cell coated filter paper was then placed into pre-warmed fresh YE media before resuspension by shaking. Cells were grown at 28 °C for sample collection in S phase.</p></sec><sec id="s4-7"><title>Affinity capture of biotinylated proteins</title><p>Cells were grown in YE media and 50 μg biotin was added 3 hr before cells were harvested. Capture of biotinylated proteins from <italic>rtf2</italic><sup>+</sup> (untagged) and <italic>rtf2-3HA-BirA</italic> samples was conducted as previously described (<xref ref-type="bibr" rid="bib19">Larochelle et al., 2019</xref>). After incubation with streptavidin Sepharose beads and subsequent washing steps, 50 µl SDS protein loading buffer (with added <italic>d</italic>-Desthiobiotin to a final concentration of 2.5 mM) was added to the beads and boiled at 95 °C for 10 min before cooling at RT for 10 min.</p></sec><sec id="s4-8"><title>Filter-aided sample preparation (FASP) for MS samples</title><p>Beads were separated from supernatant as before and 50 µl of the eluate was added to 333 µl of FASP Urea Solution (8 M Urea, 0.1 M Tris/HCl, pH 8.5, 30 mM DTT) and transferred to a Microcon Y M-30 (Millipore, 42410) filter unit. Filter units were centrifuged at 14,000 x <italic>g</italic> for 15 min followed by addition of another 200 µl FASP Urea solution and centrifuged again. Flow through was discarded before addition of 100 µl FASP IAA (8 M Urea, 50 mM iodoacetamide (IAA)) solution to each filter unit and incubation at RT for 20 min followed by centrifugation as before. Filter units then received 100 µl FASP Urea solution before centrifuging as before (this step is repeated twice for a total of three times). Flow through was discarded and 100 µl ABC buffer (50 mM Ammonium bicarbonate) was added to each filter unit before centrifuging at 14,000 x <italic>g</italic> for 10 min (this step is repeated twice for a total of three times). Flow through was discarded and 40 µl digestion solution was added to each filter unit and incubated overnight in a wet chamber. Filter units were transferred to fresh collection tubes and centrifuged at 14,000 x <italic>g</italic> for 10 min. Following this 40 µl ABC buffer was added and centrifuged again in the same conditions.</p></sec><sec id="s4-9"><title>Desalting of peptides with solid phase extraction (SPE) columns</title><p>Filtrate from the FASP digestion was acidified by addition of 100 µl Buffer A* (5% Acetonitrile, 3% Trifluoroacetic Acid). SPE columns containing 8 mg C-18 resin (Pierce, 89870) were activated by addition of 100 µl 50% methanol and centrifuged at 1500 x <italic>g</italic> for 1 min, and flow through discarded (repeated once for a total of two times). The columns were then equilibrated twice by addition of 200 µl Buffer A (5% Acetonitrile, 0.1% Formic Acid) and centrifuged as before discarding the flow through after each spin. Each sample was then added to the equilibrated spin column and centrifuged as before, washed two times with 200 µl Buffer A before elution of the desalted peptides with 100 µl of Buffer B (80% Acetonitrile, 0.1% Formic Acid). Eluates were concentrated in a speedvac to a volume of 1–2 µl and resuspended in 20 µl of Buffer A before LC-MS/MS analysis.</p></sec><sec id="s4-10"><title>LC-MS/MS run and analysis</title><p>Desalted peptide samples were analysed by a reversed-phase capillary nano liquid chromatography system (Ultimate 3000, Thermo Fisher Scientific) connected to a Q Exactive HF mass spectrometer (Thermo Scientific). Samples were injected and concentrated on a trap column (PepMap100 C18, 3 µm, 100 Å, 75 µm i.d. x 2 cm, Thermo Scientific) equilibrated with 0.05% trifluoroacetic acid in water. After switching the trap column inline, LC separations were performed on a capillary column (Acclaim PepMap100 C18, 2 µm, 100 Å, 75 µm i.d. x 25 cm, Thermo Scientific) at an eluent flow rate of 300 nl/min. Mobile phase A contained 0.1% formic acid in water, and mobile phase B contained 0.1% formic acid in 80% acetonitrile, 20% water. The column was pre-equilibrated with 5% mobile phase B and peptides were separated using a gradient of 5–44% mobile phase B within 40 min. Mass spectra were acquired in a data-dependent mode utilising a single MS survey scan (m/z 350–1650) with a resolution of 60,000 in the Orbitrap, and MS/MS scans of the 15 most intense precursor ions with a resolution of 15,000. HCD-fragmentation was performed for all ions with charge states of 2+to 5+using anormalized collision energy of 27 and isolation window of 1.4 m/z. The dynamic exclusion time was set to 20 s. Automatic gain control (AGC) was set to 3x10<sup>6</sup> for MS scans using a maximum injection time of 20ms. For MS2 scans the AGC target was set to 1x10<sup>5</sup> with a maximum injection time of 25ms.</p><p>MS and MS/MS raw data were analysed using the MaxQuant software package (version 1.6.12.0) with an implemented Andromeda peptide search engine (<xref ref-type="bibr" rid="bib39">Tyanova et al., 2016</xref>). Data were searched against the FASTA formatted Uniprot reference proteome database of <italic>Schizosaccharomyces pombe</italic> (UniprotKB UP000002485). Perseus software (version 1.6.15.0) was used to determine biologically significant hits as calculated by the Welch’s T-test.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con2"><p>Data curation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Validation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Data curation, Supervision, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Project administration, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>List of significant Mass spec. hits.</title></caption><media xlink:href="elife-78554-supp1-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>GO terms -S phase experiment.</title></caption><media xlink:href="elife-78554-supp2-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>GO terms -MMS experiment.</title></caption><media xlink:href="elife-78554-supp3-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Transcript types.</title></caption><media xlink:href="elife-78554-supp4-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>Intron retention calculations.</title></caption><media xlink:href="elife-78554-supp5-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>Gene list.</title></caption><media xlink:href="elife-78554-supp6-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp7"><label>Supplementary file 7.</label><caption><title>Data for slippage assays.</title></caption><media xlink:href="elife-78554-supp7-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-78554-mdarchecklist1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Sequence data is available under GEO dataset GSE192344.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Budden</surname><given-names>AM</given-names></name><name><surname>Eravci</surname><given-names>M</given-names></name><name><surname>Campillo-Funollet</surname><given-names>E</given-names></name><name><surname>Naiman</surname><given-names>K</given-names></name><name><surname>Carr</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title><italic>Rtf2</italic> is Important for Replication Fork Barrier Activity of <italic>RTS1</italic> via Splicing of <italic>Rtf1</italic></data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE192344">GSE192344</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Dr. Benno Kuropka from BioSupraMol, Freie Universität Berlin for performing the LC-MS runs. AMC acknowledges Welcome Trust award 110047/Z/15/Z.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ait Saada</surname><given-names>A</given-names></name><name><surname>Lambert</surname><given-names>SAE</given-names></name><name><surname>Carr</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Preserving replication fork integrity and competence via the homologous recombination pathway</article-title><source>DNA Repair</source><volume>71</volume><fpage>135</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1016/j.dnarep.2018.08.017</pub-id><pub-id pub-id-type="pmid">30220600</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolisetty</surname><given-names>MT</given-names></name><name><surname>Rajadinakaran</surname><given-names>G</given-names></name><name><surname>Graveley</surname><given-names>BR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Determining exon connectivity in complex mRNAs by nanopore sequencing</article-title><source>Genome Biology</source><volume>16</volume><elocation-id>204</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-015-0777-z</pub-id><pub-id pub-id-type="pmid">26420219</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Branon</surname><given-names>TC</given-names></name><name><surname>Bosch</surname><given-names>JA</given-names></name><name><surname>Sanchez</surname><given-names>AD</given-names></name><name><surname>Udeshi</surname><given-names>ND</given-names></name><name><surname>Svinkina</surname><given-names>T</given-names></name><name><surname>Carr</surname><given-names>SA</given-names></name><name><surname>Feldman</surname><given-names>JL</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name><name><surname>Ting</surname><given-names>AY</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Efficient proximity labeling in living cells and organisms with TurboID</article-title><source>Nature Biotechnology</source><volume>36</volume><fpage>880</fpage><lpage>887</lpage><pub-id pub-id-type="doi">10.1038/nbt.4201</pub-id><pub-id pub-id-type="pmid">30125270</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calzada</surname><given-names>A</given-names></name><name><surname>Hodgson</surname><given-names>B</given-names></name><name><surname>Kanemaki</surname><given-names>M</given-names></name><name><surname>Bueno</surname><given-names>A</given-names></name><name><surname>Labib</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Molecular anatomy and regulation of a stable replisome at a paused eukaryotic DNA replication fork</article-title><source>Genes &amp; Development</source><volume>19</volume><fpage>1905</fpage><lpage>1919</lpage><pub-id pub-id-type="doi">10.1101/gad.337205</pub-id><pub-id pub-id-type="pmid">16103218</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chia</surname><given-names>BS</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Cui</surname><given-names>A</given-names></name><name><surname>Eisenhaure</surname><given-names>T</given-names></name><name><surname>Raychowdhury</surname><given-names>R</given-names></name><name><surname>Lieb</surname><given-names>D</given-names></name><name><surname>Hacohen</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Loss of the Nuclear Protein RTF2 Enhances Influenza Virus Replication</article-title><source>Journal of Virology</source><volume>94</volume><elocation-id>e00319-20</elocation-id><pub-id pub-id-type="doi">10.1128/JVI.00319-20</pub-id><pub-id pub-id-type="pmid">32878895</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi-Rhee</surname><given-names>E</given-names></name><name><surname>Schulman</surname><given-names>H</given-names></name><name><surname>Cronan</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Promiscuous protein biotinylation by <italic>Escherichia coli</italic> biotin protein ligase</article-title><source>Protein Science</source><volume>13</volume><fpage>3043</fpage><lpage>3050</lpage><pub-id pub-id-type="doi">10.1110/ps.04911804</pub-id><pub-id pub-id-type="pmid">15459338</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Codlin</surname><given-names>S</given-names></name><name><surname>Dalgaard</surname><given-names>JZ</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Complex mechanism of site-specific DNA replication termination in fission yeast</article-title><source>The EMBO Journal</source><volume>22</volume><fpage>3431</fpage><lpage>3440</lpage><pub-id pub-id-type="doi">10.1093/emboj/cdg330</pub-id><pub-id pub-id-type="pmid">12840005</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daigaku</surname><given-names>Y</given-names></name><name><surname>Keszthelyi</surname><given-names>A</given-names></name><name><surname>Müller</surname><given-names>CA</given-names></name><name><surname>Miyabe</surname><given-names>I</given-names></name><name><surname>Brooks</surname><given-names>T</given-names></name><name><surname>Retkute</surname><given-names>R</given-names></name><name><surname>Hubank</surname><given-names>M</given-names></name><name><surname>Nieduszynski</surname><given-names>CA</given-names></name><name><surname>Carr</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A global profile of replicative polymerase usage</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>22</volume><fpage>192</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1038/nsmb.2962</pub-id><pub-id pub-id-type="pmid">25664722</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalgaard</surname><given-names>JZ</given-names></name><name><surname>Klar</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>swi1 and swi3 perform imprinting, pausing, and termination of DNA replication in <italic>S. pombe</italic></article-title><source>Cell</source><volume>102</volume><fpage>745</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)00063-5</pub-id><pub-id pub-id-type="pmid">11030618</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalgaard</surname><given-names>JZ</given-names></name><name><surname>Klar</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A DNA replication-arrest site RTS1 regulates imprinting by determining the direction of replication at mat1 in <italic>S. pombe</italic></article-title><source>Genes &amp; Development</source><volume>15</volume><fpage>2060</fpage><lpage>2068</lpage><pub-id pub-id-type="doi">10.1101/gad.200801</pub-id><pub-id pub-id-type="pmid">11511538</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dungrawala</surname><given-names>H</given-names></name><name><surname>Rose</surname><given-names>KL</given-names></name><name><surname>Bhat</surname><given-names>KP</given-names></name><name><surname>Mohni</surname><given-names>KN</given-names></name><name><surname>Glick</surname><given-names>GG</given-names></name><name><surname>Couch</surname><given-names>FB</given-names></name><name><surname>Cortez</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The replication checkpoint prevents two types of fork collapse without regulating replisome stability</article-title><source>Molecular Cell</source><volume>59</volume><fpage>998</fpage><lpage>1010</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.07.030</pub-id><pub-id pub-id-type="pmid">26365379</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eydmann</surname><given-names>T</given-names></name><name><surname>Sommariva</surname><given-names>E</given-names></name><name><surname>Inagawa</surname><given-names>T</given-names></name><name><surname>Mian</surname><given-names>S</given-names></name><name><surname>Klar</surname><given-names>AJS</given-names></name><name><surname>Dalgaard</surname><given-names>JZ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Rtf1-mediated eukaryotic site-specific replication termination</article-title><source>Genetics</source><volume>180</volume><fpage>27</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1534/genetics.108.089243</pub-id><pub-id pub-id-type="pmid">18723894</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inagawa</surname><given-names>T</given-names></name><name><surname>Yamada-Inagawa</surname><given-names>T</given-names></name><name><surname>Eydmann</surname><given-names>T</given-names></name><name><surname>Mian</surname><given-names>IS</given-names></name><name><surname>Wang</surname><given-names>TS</given-names></name><name><surname>Dalgaard</surname><given-names>JZ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title><italic>Schizosaccharomyces pombe</italic> Rtf2 mediates site-specific replication termination by inhibiting replication restart</article-title><source>PNAS</source><volume>106</volume><fpage>7927</fpage><lpage>7932</lpage><pub-id pub-id-type="doi">10.1073/pnas.0812323106</pub-id><pub-id pub-id-type="pmid">19416828</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iraqui</surname><given-names>I</given-names></name><name><surname>Chekkal</surname><given-names>Y</given-names></name><name><surname>Jmari</surname><given-names>N</given-names></name><name><surname>Pietrobon</surname><given-names>V</given-names></name><name><surname>Fréon</surname><given-names>K</given-names></name><name><surname>Costes</surname><given-names>A</given-names></name><name><surname>Lambert</surname><given-names>SAE</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Recovery of arrested replication forks by homologous recombination is error-prone</article-title><source>PLOS Genetics</source><volume>8</volume><elocation-id>e1002976</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002976</pub-id><pub-id pub-id-type="pmid">23093942</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>M</given-names></name><name><surname>Fiddes</surname><given-names>IT</given-names></name><name><surname>Miga</surname><given-names>KH</given-names></name><name><surname>Olsen</surname><given-names>HE</given-names></name><name><surname>Paten</surname><given-names>B</given-names></name><name><surname>Akeson</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Improved data analysis for the MinION nanopore sequencer</article-title><source>Nature Methods</source><volume>12</volume><fpage>351</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3290</pub-id><pub-id pub-id-type="pmid">25686389</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keszthelyi</surname><given-names>A</given-names></name><name><surname>Daigaku</surname><given-names>Y</given-names></name><name><surname>Ptasińska</surname><given-names>K</given-names></name><name><surname>Miyabe</surname><given-names>I</given-names></name><name><surname>Carr</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mapping ribonucleotides in genomic DNA and exploring replication dynamics by polymerase usage sequencing (Pu-seq)</article-title><source>Nature Protocols</source><volume>10</volume><fpage>1786</fpage><lpage>1801</lpage><pub-id pub-id-type="doi">10.1038/nprot.2015.116</pub-id><pub-id pub-id-type="pmid">26492137</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kottemann</surname><given-names>MC</given-names></name><name><surname>Conti</surname><given-names>BA</given-names></name><name><surname>Lach</surname><given-names>FP</given-names></name><name><surname>Smogorzewska</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Removal of RTF2 from stalled replisomes promotes maintenance of genome integrity</article-title><source>Molecular Cell</source><volume>69</volume><fpage>24</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.11.035</pub-id><pub-id pub-id-type="pmid">29290612</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname><given-names>S</given-names></name><name><surname>Carr</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Impediments to replication fork movement: stabilisation, reactivation and genome instability</article-title><source>Chromosoma</source><volume>122</volume><fpage>33</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1007/s00412-013-0398-9</pub-id><pub-id pub-id-type="pmid">23446515</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larochelle</surname><given-names>M</given-names></name><name><surname>Bergeron</surname><given-names>D</given-names></name><name><surname>Arcand</surname><given-names>B</given-names></name><name><surname>Bachand</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Proximity-dependent biotinylation mediated by TurboID to identify protein-protein interaction networks in yeast</article-title><source>Journal of Cell Science</source><volume>132</volume><elocation-id>jcs232249</elocation-id><pub-id pub-id-type="doi">10.1242/jcs.232249</pub-id><pub-id pub-id-type="pmid">31064814</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larson</surname><given-names>A</given-names></name><name><surname>Fair</surname><given-names>BJ</given-names></name><name><surname>Pleiss</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Interconnections between RNA-Processing pathways revealed by a sequencing-based genetic screen for Pre-mRNA splicing mutants in fission yeast</article-title><source>G3: Genes, Genomes, Genetics</source><volume>6</volume><fpage>1513</fpage><lpage>1523</lpage><pub-id pub-id-type="doi">10.1534/g3.116.027508</pub-id><pub-id pub-id-type="pmid">27172183</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Minimap2: pairwise alignment for nucleotide sequences</article-title><source>Bioinformatics</source><volume>34</volume><fpage>3094</fpage><lpage>3100</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty191</pub-id><pub-id pub-id-type="pmid">29750242</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magdalou</surname><given-names>I</given-names></name><name><surname>Lopez</surname><given-names>BS</given-names></name><name><surname>Pasero</surname><given-names>P</given-names></name><name><surname>Lambert</surname><given-names>SAE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The causes of replication stress and their consequences on genome stability and cell fate</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>30</volume><fpage>154</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2014.04.035</pub-id><pub-id pub-id-type="pmid">24818779</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malkova</surname><given-names>A</given-names></name><name><surname>Ira</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Break-induced replication: functions and molecular mechanism</article-title><source>Current Opinion in Genetics &amp; Development</source><volume>23</volume><fpage>271</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1016/j.gde.2013.05.007</pub-id><pub-id pub-id-type="pmid">23790415</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyabe</surname><given-names>I</given-names></name><name><surname>Mizuno</surname><given-names>K</given-names></name><name><surname>Keszthelyi</surname><given-names>A</given-names></name><name><surname>Daigaku</surname><given-names>Y</given-names></name><name><surname>Skouteri</surname><given-names>M</given-names></name><name><surname>Mohebi</surname><given-names>S</given-names></name><name><surname>Kunkel</surname><given-names>TA</given-names></name><name><surname>Murray</surname><given-names>JM</given-names></name><name><surname>Carr</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Polymerase δ replicates both strands after homologous recombination-dependent fork restart</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>22</volume><fpage>932</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.1038/nsmb.3100</pub-id><pub-id pub-id-type="pmid">26436826</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizuno</surname><given-names>K</given-names></name><name><surname>Lambert</surname><given-names>S</given-names></name><name><surname>Baldacci</surname><given-names>G</given-names></name><name><surname>Murray</surname><given-names>JM</given-names></name><name><surname>Carr</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Nearby inverted repeats fuse to generate acentric and dicentric palindromic chromosomes by a replication template exchange mechanism</article-title><source>Genes &amp; Development</source><volume>23</volume><fpage>2876</fpage><lpage>2886</lpage><pub-id pub-id-type="doi">10.1101/gad.1863009</pub-id><pub-id pub-id-type="pmid">20008937</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizuno</surname><given-names>K</given-names></name><name><surname>Miyabe</surname><given-names>I</given-names></name><name><surname>Schalbetter</surname><given-names>SA</given-names></name><name><surname>Carr</surname><given-names>AM</given-names></name><name><surname>Murray</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Recombination-restarted replication makes inverted chromosome fusions at inverted repeats</article-title><source>Nature</source><volume>493</volume><fpage>246</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1038/nature11676</pub-id><pub-id pub-id-type="pmid">23178809</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Moreno</surname><given-names>S</given-names></name><name><surname>Klar</surname><given-names>A</given-names></name><name><surname>Nurse</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1991">1991</year><chapter-title>[56] molecular genetic analysis of fission yeast Schizosaccharomyces Pombe</chapter-title><source>In Guide to Yeast Genetics and Molecular Biology: Methods in Enzymology</source><publisher-name>Elsevier</publisher-name><fpage>795</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.1016/0076-6879(91)94059-L</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naiman</surname><given-names>K</given-names></name><name><surname>Campillo-Funollet</surname><given-names>E</given-names></name><name><surname>Watson</surname><given-names>AT</given-names></name><name><surname>Budden</surname><given-names>A</given-names></name><name><surname>Miyabe</surname><given-names>I</given-names></name><name><surname>Carr</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Replication dynamics of recombination-dependent replication forks</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>923</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-21198-0</pub-id><pub-id pub-id-type="pmid">33568651</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ou</surname><given-names>Y-N</given-names></name><name><surname>Yang</surname><given-names>Y-X</given-names></name><name><surname>Deng</surname><given-names>Y-T</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>B-S</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y-J</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Suckling</surname><given-names>J</given-names></name><name><surname>Tan</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>J-T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Identification of novel drug targets for Alzheimer’s disease by integrating genetics and proteomes from brain and blood</article-title><source>Molecular Psychiatry</source><volume>26</volume><fpage>6065</fpage><lpage>6073</lpage><pub-id pub-id-type="doi">10.1038/s41380-021-01251-6</pub-id><pub-id pub-id-type="pmid">34381170</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pertea</surname><given-names>G</given-names></name><name><surname>Pertea</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>GFF Utilities: GffRead and GffCompare</article-title><source>F1000Research</source><volume>9</volume><elocation-id>ISCB Comm J-304</elocation-id><pub-id pub-id-type="doi">10.12688/f1000research.23297.2</pub-id><pub-id pub-id-type="pmid">32489650</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pozzi</surname><given-names>B</given-names></name><name><surname>Bragado</surname><given-names>L</given-names></name><name><surname>Will</surname><given-names>CL</given-names></name><name><surname>Mammi</surname><given-names>P</given-names></name><name><surname>Risso</surname><given-names>G</given-names></name><name><surname>Urlaub</surname><given-names>H</given-names></name><name><surname>Lührmann</surname><given-names>R</given-names></name><name><surname>Srebrow</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>SUMO conjugation to spliceosomal proteins is required for efficient pre-mRNA splicing</article-title><source>Nucleic Acids Research</source><volume>45</volume><fpage>6729</fpage><lpage>6745</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx213</pub-id><pub-id pub-id-type="pmid">28379520</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pozzi</surname><given-names>B</given-names></name><name><surname>Mammi</surname><given-names>P</given-names></name><name><surname>Bragado</surname><given-names>L</given-names></name><name><surname>Giono</surname><given-names>LE</given-names></name><name><surname>Srebrow</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>When SUMO met splicing</article-title><source>RNA Biology</source><volume>15</volume><fpage>689</fpage><lpage>695</lpage><pub-id pub-id-type="doi">10.1080/15476286.2018.1457936</pub-id><pub-id pub-id-type="pmid">29741121</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raj</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>YI</given-names></name><name><surname>Wong</surname><given-names>G</given-names></name><name><surname>Humphrey</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Ramdhani</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y-C</given-names></name><name><surname>Ng</surname><given-names>B</given-names></name><name><surname>Gupta</surname><given-names>I</given-names></name><name><surname>Haroutunian</surname><given-names>V</given-names></name><name><surname>Schadt</surname><given-names>EE</given-names></name><name><surname>Young-Pearse</surname><given-names>T</given-names></name><name><surname>Mostafavi</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>De Jager</surname><given-names>PL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer’s disease susceptibility</article-title><source>Nature Genetics</source><volume>50</volume><fpage>1584</fpage><lpage>1592</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0238-1</pub-id><pub-id pub-id-type="pmid">30297968</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Kanno</surname><given-names>T</given-names></name><name><surname>Liang</surname><given-names>S-C</given-names></name><name><surname>Chen</surname><given-names>P-Y</given-names></name><name><surname>Liao</surname><given-names>W-W</given-names></name><name><surname>Lin</surname><given-names>W-D</given-names></name><name><surname>Matzke</surname><given-names>AJM</given-names></name><name><surname>Matzke</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>An Rtf2 domain-dontaining protein influences Pre-mRNA splicing and is essential for embryonic development in <italic>Arabidopsis thaliana</italic></article-title><source>Genetics</source><volume>200</volume><fpage>523</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1534/genetics.115.176438</pub-id><pub-id pub-id-type="pmid">25819795</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>P</given-names></name><name><surname>Halova</surname><given-names>L</given-names></name><name><surname>Hagan</surname><given-names>IM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Highly Synchronous Mitotic progression in <italic>Schizosaccharomyces pombe</italic> upon relief of transient Cdc2-asM17 inhibition</article-title><source>Methods in Molecular Biology</source><volume>2329</volume><fpage>123</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1007/978-1-0716-1538-6_10</pub-id><pub-id pub-id-type="pmid">34085220</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suo</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zeng</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Yun</surname><given-names>J</given-names></name><name><surname>Guan</surname><given-names>XY</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>NRIP3 upregulation confers resistance to chemoradiotherapy in ESCC via RTF2 removal by accelerating ubiquitination and degradation of RTF2</article-title><source>Oncogenesis</source><volume>9</volume><elocation-id>75</elocation-id><pub-id pub-id-type="doi">10.1038/s41389-020-00260-4</pub-id><pub-id pub-id-type="pmid">32839439</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teixeira-Silva</surname><given-names>A</given-names></name><name><surname>Ait Saada</surname><given-names>A</given-names></name><name><surname>Hardy</surname><given-names>J</given-names></name><name><surname>Iraqui</surname><given-names>I</given-names></name><name><surname>Nocente</surname><given-names>MC</given-names></name><name><surname>Fréon</surname><given-names>K</given-names></name><name><surname>Lambert</surname><given-names>SAE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The end-joining factor Ku acts in the end-resection of double strand break-free arrested replication forks</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>1982</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-02144-5</pub-id><pub-id pub-id-type="pmid">29215009</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trempe</surname><given-names>J-F</given-names></name><name><surname>Brown</surname><given-names>NR</given-names></name><name><surname>Lowe</surname><given-names>ED</given-names></name><name><surname>Gordon</surname><given-names>C</given-names></name><name><surname>Campbell</surname><given-names>ID</given-names></name><name><surname>Noble</surname><given-names>MEM</given-names></name><name><surname>Endicott</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Mechanism of Lys48-linked polyubiquitin chain recognition by the Mud1 UBA domain</article-title><source>The EMBO Journal</source><volume>24</volume><fpage>3178</fpage><lpage>3189</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600797</pub-id><pub-id pub-id-type="pmid">16138082</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyanova</surname><given-names>S</given-names></name><name><surname>Temu</surname><given-names>T</given-names></name><name><surname>Cox</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The MaxQuant computational platform for mass spectrometry-based shotgun proteomics</article-title><source>Nature Protocols</source><volume>11</volume><fpage>2301</fpage><lpage>2319</lpage><pub-id pub-id-type="doi">10.1038/nprot.2016.136</pub-id><pub-id pub-id-type="pmid">27809316</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>AT</given-names></name><name><surname>Garcia</surname><given-names>V</given-names></name><name><surname>Bone</surname><given-names>N</given-names></name><name><surname>Carr</surname><given-names>AM</given-names></name><name><surname>Armstrong</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Gene tagging and gene replacement using recombinase-mediated cassette exchange in <italic>Schizosaccharomyces pombe</italic></article-title><source>Gene</source><volume>407</volume><fpage>63</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2007.09.024</pub-id><pub-id pub-id-type="pmid">18054176</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watts</surname><given-names>FZ</given-names></name><name><surname>Skilton</surname><given-names>A</given-names></name><name><surname>Ho</surname><given-names>JC-Y</given-names></name><name><surname>Boyd</surname><given-names>LK</given-names></name><name><surname>Trickey</surname><given-names>MAM</given-names></name><name><surname>Gardner</surname><given-names>L</given-names></name><name><surname>Ogi</surname><given-names>F-X</given-names></name><name><surname>Outwin</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The role of <italic>Schizosaccharomyces pombe</italic> SUMO ligases in genome stability</article-title><source>Biochemical Society Transactions</source><volume>35</volume><fpage>1379</fpage><lpage>1384</lpage><pub-id pub-id-type="doi">10.1042/BST0351379</pub-id><pub-id pub-id-type="pmid">18031226</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wingo</surname><given-names>AP</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Gerasimov</surname><given-names>ES</given-names></name><name><surname>Gockley</surname><given-names>J</given-names></name><name><surname>Logsdon</surname><given-names>BA</given-names></name><name><surname>Duong</surname><given-names>DM</given-names></name><name><surname>Dammer</surname><given-names>EB</given-names></name><name><surname>Robins</surname><given-names>C</given-names></name><name><surname>Beach</surname><given-names>TG</given-names></name><name><surname>Reiman</surname><given-names>EM</given-names></name><name><surname>Epstein</surname><given-names>MP</given-names></name><name><surname>De Jager</surname><given-names>PL</given-names></name><name><surname>Lah</surname><given-names>JJ</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>Seyfried</surname><given-names>NT</given-names></name><name><surname>Levey</surname><given-names>AI</given-names></name><name><surname>Wingo</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis</article-title><source>Nature Genetics</source><volume>53</volume><fpage>143</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1038/s41588-020-00773-z</pub-id><pub-id pub-id-type="pmid">33510477</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>C</given-names></name><name><surname>Horner</surname><given-names>N</given-names></name><name><surname>Griffiths</surname><given-names>S</given-names></name><name><surname>Parker</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Wf-Isoforms</data-title><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/epi2me-labs/wf-isoforms">https://github.com/epi2me-labs/wf-isoforms</ext-link></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78554.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Shinohara</surname><given-names>Akira</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/035t8zc32</institution-id><institution>Osaka University</institution></institution-wrap><country>Japan</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.03.10.483798" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.03.10.483798"/></front-stub><body><p>This valuable work reports a new regulation of the RNA splicing of a fission yeast gene necessary for the DNA replication fork barrier. Using molecular genetic approaches combined with replication fork profiling analysis, the authors provided significant evidence that the Rtf2 is a splicing regulator specific to the <italic>rtf1</italic> gene essential for the fork barrier. The study is of interest to researchers in the fields of DNA replication and homologous recombination as well as RNA splicing.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78554.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Shinohara</surname><given-names>Akira</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/035t8zc32</institution-id><institution>Osaka University</institution></institution-wrap><country>Japan</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Shinohara</surname><given-names>Akira</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/035t8zc32</institution-id><institution>Osaka University</institution></institution-wrap><country>Japan</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Lambert</surname><given-names>Sarah</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04t0gwh46</institution-id><institution>Institut Curie</institution></institution-wrap><country>France</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Ren</surname><given-names>Jie</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/034t30j35</institution-id><institution>Beijing Institute of Genomics, Chinese Academy of Sciences</institution></institution-wrap><country>China</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.03.10.483798">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.03.10.483798v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;<italic>S. pombe Rtf2</italic> is Important for Replication Fork Barrier Activity of <italic>RTS1</italic> via Splicing of <italic>Rtf1</italic>&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Akira Shinohara as Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Jessica Tyler as the Senior Editor. The following individuals involved in the review of your submission have agreed to reveal their identity: Sarah Lambert (Reviewer #2); Jie Ren (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>Importantly, to strengthen your conclusion in the paper, we recommend one experiment described below. And also you see the comments from three independent reviewers.</p><p>Importantly, you showed expression of Rtf1 protein with an insertion of 15 amino acids from the second intron in the rtf2 mutant (Figure 3E, page 12, lines 487-488), which is non-functional for activity at RTS1. Please demonstrate that Rtf1 with extra 15 amino acids from the intron 2 (e.g. by inserting the 15 amino acid sequence in Rtf1delta-int construct in Figure 4) is NOT functional either by in vivo complementation assay (Pu-seq and/or ura4 reversion assay), or ChIP to the RTS1 site, or by in vitro biochemical analysis of DNA binding for purified wild-type Rtf1 protein and Rtf1 with the extra 15 amino acids.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>Please provide results that indicate the molecular mechanism of Rtf2 controlling the splicing of Rtf1 RNA.</p><p>1. Although the authors showed the splicing of only the second (and sixth) intron of Rtf1 RNA is defective in the rtf2 mutant (Figure 3D), the authors introduced an intronless RTF1 gene rather than the RTF1 without the second intron for their complementation assay (Figure 4). It would be important to check whether Rtf1 cDNA with intron2 does not complement the rtf1 deletion and/or rtf2 deletion.</p><p>2. In the same line to point #1, the authors need to introduce the second intron of the RTF1 gene to a reporter gene to check the dependency of the intron removal on the Rtf2.</p><p>3. The authors showed the expression of Rtf1 protein with 15 amino acids from the second intron in the rtf2 mutant (Figure 3E, page 12, lines 487-488), which is non-functional for RTS1 activity. It is important to confirm this claim by experimentation as in point #1. In another word, it is critical to show that Rtf1 with extra 15 amino acids from the intron 2 is NOT functional either by simple complementation assay or biochemical analysis of DNA binding for purified wild-type Rtf1 protein and Rtf1 with the extra 15 amino acids.</p><p>4. An RT-PCR product for the removal of Rtf2 second intron in the rtf2 mutant migrates a bit faster on the gel than the product of the &quot;retained&quot; (Figure 3D). The authors need to confirm the DNA sequence of the retained products in both strains.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78554.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>Importantly, to strengthen your conclusion in the paper, we recommend one experiment described below. And also you see the comments from three independent reviewers.</p><p>Importantly, you showed expression of Rtf1 protein with an insertion of 15 amino acids from the second intron in the rtf2 mutant (Figure 3E, page 12, lines 487-488), which is non-functional for activity at RTS1. Please demonstrate that Rtf1 with extra 15 amino acids from the intron 2 (e.g. by inserting the 15 amino acid sequence in Rtf1delta-int construct in Figure 4) is NOT functional either by in vivo complementation assay (Pu-seq and/or ura4 reversion assay), or ChIP to the RTS1 site, or by in vitro biochemical analysis of DNA binding for purified wild-type Rtf1 protein and Rtf1 with the extra 15 amino acids.</p></disp-quote><p>We have carried out an experiment where we express the Rtf2 with the extra 15 amino acids and demonstrate this is non-functional. It is now presented in a new Supplementary Figure.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>Please provide results that indicate the molecular mechanism of Rtf2 controlling the splicing of Rtf1 RNA.</p></disp-quote><p>We believe this to be beyond the scope of the manuscript (and the intellectual expertise of the laboratory).</p><disp-quote content-type="editor-comment"><p>1. Although the authors showed the splicing of only the second (and sixth) intron of Rtf1 RNA is defective in the rtf2 mutant (Figure 3D), the authors introduced an intronless RTF1 gene rather than the RTF1 without the second intron for their complementation assay (Figure 4). It would be important to check whether Rtf1 cDNA with intron2 does not complement the rtf1 deletion and/or rtf2 deletion.</p></disp-quote><p>We did not perform this experiment. The cDNA sequencing clearly shows that the major form of rtf1 mRNA in rtf2D cells contains only intron 2. Our demonstration (new supplementary figure) that the Rtf1 which contains the resulting additional amino acids is non-functional confirms the conclusions we draw from the presented data.</p><disp-quote content-type="editor-comment"><p>2. In the same line to point #1, the authors need to introduce the second intron of the RTF1 gene to a reporter gene to check the dependency of the intron removal on the Rtf2.</p></disp-quote><p>Our data suggest that introns that are retained in rtf2D cells when the intron is adjacent to an exon with a low G/C content. A reasonable hypothesis would be that Rtf2-depenedance is influenced by the downstream exon. Thus, we would predict that simply introducing an intron 2 into a random exon would not necessarily result in retention.</p><disp-quote content-type="editor-comment"><p>3. The authors showed the expression of Rtf1 protein with 15 amino acids from the second intron in the rtf2 mutant (Figure 3E, page 12, lines 487-488), which is non-functional for RTS1 activity. It is important to confirm this claim by experimentation as in point #1. In another word, it is critical to show that Rtf1 with extra 15 amino acids from the intron 2 is NOT functional either by simple complementation assay or biochemical analysis of DNA binding for purified wild-type Rtf1 protein and Rtf1 with the extra 15 amino acids.</p></disp-quote><p>A complementation experiment has been done and is presented in a new supplementary figure.</p><disp-quote content-type="editor-comment"><p>4. An RT-PCR product for the removal of Rtf2 second intron in the rtf2 mutant migrates a bit faster on the gel than the product of the &quot;retained&quot; (Figure 3D). The authors need to confirm the DNA sequence of the retained products in both strains.</p></disp-quote><p>The sequence of the retained product is evident from the sequencing of the cDNA. We do not understand why sequencing the product of a PCR reaction would add any further information.</p></body></sub-article></article>